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ABSTRACT 
 
The serial interval (SI), defined as the symptom time between an infector and an infectee, 
is widely used to better understand transmission patterns of an infectious disease. 
Estimating the SI for tuberculosis (TB) is complicated by the slow progression from 
asymptomatic infection to active, symptomatic disease, and the fact that there is only a 5-
10% lifetime risk of developing active TB disease. Furthermore, the time of symptom 
onset for infectors and infectees is rarely observed accurately. In this dissertation, we first 
conduct a systematic literature review to demonstrate the limited methods currently 
available to estimate the serial interval for TB as well as the few estimates that have been 
published. Secondly, under the assumption of an ideal scenario where all SIs are 
observed with precision, we evaluate the effect of prior information on estimating the SI 
in a Bayesian framework. Thirdly, we apply cure models, proposed by Boag in 1949, to 
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estimate the SI for TB in a Bayesian framework. We show that the cure models perform 
better in the presence of credible prior information on the proportion of the study 
population that develop active TB disease, and should be chosen over traditional survival 
models which assume that all of the study population will eventually have the event of 
interest—active TB disease. Next, we modify the method by Reich et al. in 2009 by using 
a Riemann sum to approximate the likelihood function that involves a double integral. In 
doing so, we are able to reduce the computing time of the approximation method by 
around 50%. We are also able to relax the assumption of uniformity on the censoring 
intervals. We show that when using weights that are consistent with the underlying 
skewness of the intervals, the proposed approaches consistently produce more accurate 
estimates than the existing approaches. We provide SI estimates for TB using empirical 
datasets from Brazil and USA/Canada. 
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Chapter 1 Quantifying TB transmission: a systematic review of reproduction 
number and serial interval estimates for tuberculosis 
 
1.1.1 Introduction 
 
Tuberculosis (TB), an airborne bacterial infection caused by the organism 
Mycobacterium tuberculosis (Mtb), has surpassed HIV/AIDS as the leading cause of 
death due to a single infectious organism worldwide [1]. It primarily attacks the lungs but 
can also infect other areas of the body [2,3] . Those exposed to Mtb often develop latent 
TB infection (LTBI) and have a 5-10% lifetime risk of progressing to active TB [4,5]. 
Worldwide, 2-3 billion people are infected with TB; an estimated 10.4 million people 
developed active TB disease in 2015 [4]. Major innovations in strategies and tools to 
monitor the success of new strategies are needed to achieve the World Health 
Organization (WHO)’s ENDTB goals of reducing TB deaths by 95% and new cases by 
90% by 2035 [1].  
 
The reproductive number and serial interval (SI) are two key quantities in describing 
transmission of an infectious disease. The reproductive number is defined as the average 
number of secondary cases a primary infectious case will produce. In a totally susceptible 
population, it is referred to as the basic reproductive number (R0); it is referred to as the 
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effective reproductive number (Re) if the population includes both susceptible and non-
susceptible persons [6]. An Re greater than 1 indicates that the disease will continue to 
spread while an Re less than 1 indicates that the disease will eventually die out. Although 
the reproductive number is usually defined as the average number of secondary cases, it 
is occasionally defined as the average number of secondary infections [7–9], a distinction 
that is important for a disease with a long incubation period (the time between infection 
and developing symptomatic disease) and/or only a fraction of infections progressing to 
disease. Depending on the setting, the reproductive number can be expressed as a 
function of parameters such as infection rate, contact rate, recovery rate, making it useful 
in determining whether or not a disease can spread through a population. 
 
The serial interval (SI), defined as the time between disease symptom onset of a case and 
that of its infector [10], is a surrogate for the generation interval— an unobservable 
quantity defined as the time between the infection of a case and the time of infection of 
its infector [11]. The SI is an important quantity in the interpretation of infectious disease 
surveillance data, in the identification of outbreaks, and in the optimization of quarantine 
and contact tracing. 
 
These two quantities have been used to inform control policies during outbreaks [12] by 
quantifying the transmission of infectious diseases such as influenza A (H1N1) 
[10,12,13], Severe Acute Respiratory Syndrome (SARS) [11,14], and Ebola [15,16], 
where progression to disease upon transmission occurs quickly. For example, Wallinga 
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and Teunis [17] in 2004 demonstrated the impact of the first global alert against SARS on 
the change of the effective reproductive number. 
 
TB has a slower transmission rate due to its much longer incubation period. Of the 5-10% 
of infections that develop into active (symptomatic and infectious) TB disease, it is 
thought that the majority occur within the first two years after infection [2,4,5], although 
active TB disease can develop decades after initial infection [18]. This is much longer 
than the aforementioned infectious diseases where cases show symptoms within days of 
infection. Although there is an increasing consensus that some transmission events may 
occur before the infector shows symptoms, many likely occur after the infector is 
symptomatic, therefore, the longer the incubation period is, the longer the SI (Figure 1.1).  
 
Development of TB disease can be caused by de novo infection, reactivation of the same 
bacterial strain as a previous infection [4,19] or by infection with a bacterial strain 
different from the original infection (reinfection TB). This complicates estimation of the 
SI, unless molecular techniques are used to distinguish reinfection and reactivation [19]. 
To our knowledge, there has been no systematic review of methods to estimate the SI and 
reproductive number for TB. Therefore, in this paper we systematically review the 
literature to examine the methods applied to the estimation of TB transmission 
parameters and the estimates obtained from these methods. This compilation informs the 
gaps in our understanding of TB and identifies areas where further research is needed to 
develop methods to better understand TB transmission. 
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1.2 Review of Literature on Key Transmission Parameters for TB 
 
1.2.1 Method 
 
We conducted two searches in PubMed for publications in English—one for tuberculosis 
and serial interval; one for tuberculosis and reproductive number: 
 
1. Tuberculosis and serial interval: 
(“Tuberculosis”[MeSH] OR “Mycobacterium tuberculosis”[MeSH] OR 
“tuberculosis”[TI] ) and ("serial interval"[tiab] or "generation interval"[tiab] or "serial 
distribution" [tiab] or “secondary infections” [tiab] or “secondary cases” [tiab]) 
 
2. Tuberculosis and reproductive number:  
(“Tuberculosis”[MeSH] OR “Mycobacterium tuberculosis”[MeSH] OR 
“tuberculosis”[TI] OR “pulmonary, tuberculosis [MeSH]”) and (“reproductive 
number”[tiab] or “reproduction number”[tiab] or “reproductive rate”[tiab] or 
“reproduction rate”[tiab] or “reproduction ratio” [tiab] or “reproductive ratio”[tiab] or 
“reproduction value”[tiab] or “reproductive value”[tiab] or “R0” [tiab] or “secondary 
infections” [tiab] or “secondary cases” [tiab]) 
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Titles and abstracts of the publications referenced in the articles we found were reviewed 
for inclusion for either parameter. For the SI, as limited number of publications met our 
inclusion criteria, we also reviewed the titles and abstracts of publications that cited the 
serial interval articles that we included in a full-text review.  
 
Two reviewers (two of YM, HEJ, LFW) independently screened all titles and abstracts, 
resolving discrepancies by consensus. Each publication was then independently reviewed 
by two reviewers (two of YM, HEJ, LFW) for inclusion. From the included articles, the 
same pairs of reviewers extracted the following details for all parameter estimates (if 
available): point estimates, confidence intervals, ranges, sample size and location/setting. 
We summarized the methods for analysis and aggregated those with similar estimation 
approaches. 
 
1.2.2 Results 
 
Serial interval  
The serial interval query returned 171 articles (Figure 1.2), of which 163 were excluded 
as they did not present any estimates. Leung et al. [20] reported the SI as the time from 
identification of primary case to secondary case as median 1.4 years (range: 0.4-5.2 
years). This study used household transmission data from Hong Kong and focused on 
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MDR- and XDR-TB. Vynnycky and Fine [21] analyzed a population of white males in 
England and Wales in the 20th century using a mathematical compartmental model to 
estimate the SI as dependent on the age when infection occurred, distinguishing 
reinfection and reactivation in the model. In this model, the risk of developing disease 
was calibrated on incidence data. The estimates were presented as a frequency 
distribution. The most frequent time to develop disease was estimated at: between 20 to 
30 years due to reinfection for those infected in the first year of life; between 10 and 14 
years due to reinfection for those infected at age 10; less than 5 years due to recent 
infection for those infected at age 20 and those infected at age 40. ten Asbroek et al. [22] 
analyzed genetic data for a Dutch sample from 1993-1996 to link infectors and infected 
people using DNA fingerprinting based on restriction fragment length polymorphism 
(RFLP) and estimated the SI at a geometric mean of 0.57 years (95% Confidence Interval 
(CI): 0.44-0.73). In this 4-year study, the probability of observing both the infector and 
the infected person depended on the time interval between isolates— the shorter this time 
interval was, the more likely that this couple was observed. Therefore, the observed SIs 
were weighted by the inverse of the difference between the length of the study period and 
the time between isolates of the infector and the infected person, allowing a rough 
correction for underrepresentation of longer SIs. 
 
Two articles that cited the articles that met our inclusion criteria in the PubMed search 
reported estimates of the SI and were included for full-text review. Borgdorff in [23] used 
the same method on genetic data as [22] to estimate the median SI as 1.44 years (95% CI 
1.29-1.63 years) for a Dutch sample from 1993-2007. Brooks-Pollock [24] in 2011 
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analyzed cross-sectional household data for a sample in Lima, Peru from 1996-2002 and 
reported the time between the diagnosis of the infector and the infected person as an 
estimate for the SI with mean at 3.5 years and the median at 1.65 years.  
 
Reproductive number 
Two hundred and thirty-seven articles were identified for the reproductive number of TB. 
Additionally, 6 articles were included based on reviewing titles and abstracts of the 
articles that were referenced in the 237 articles, making the total number of articles 243. 
Fifty-six articles met our inclusion criteria and are described below. Three articles used 
either approximate Bayesian or exact likelihood methods, 24 articles used either a 
mathematical model fit with empirical data or a descriptive/regression approach on 
empirical data, and 29 articles used a simulation based mathematical model (Figure 1.3). 
Explicit estimates were extracted and summarized in Figure 1.4. The estimates range 
from as low as 0.26 for the Netherlands in 1993-2007 to as high as 4.3 in China in 2012.  
 
Three articles (Table 1.2) used the same genetic RFLP data from TB diseased individuals 
during an outbreak in San Francisco in 1994 [25]. They all estimated the effective 
reproductive number in a Bayesian framework. Tanaka et al. [26] used an approximated 
computation method to obtain an estimate of 3.4 (95% CI: 1.4-79.7). Stadler [27] in 2013 
used an exact likelihood method to obtain an estimate of 1.02 (95% CI: 1.01-1.04) and 
claimed that the difference from the estimate in [26] was due to the lack of precision in 
the approximation of the posterior distribution. Aandahl et al. [28] in 2014 reconciled the 
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two methods by specifying an informative prior for two parameters in [26] and improving 
the convergence performance of the Markov chain Monte Carlo (MCMC) sampler in 
[27]. The reconciled estimates were: 2.1 (95% CI: 1.54-2.66) for the approximate method 
in [26] and 2.05 (95% CI: 1.55-2.63) for the exact method in [27]. These papers used the 
same model but differed in the methods used to obtain the estimates. The assumptions of 
the model are listed in Table 1.2. 
 
Twenty-four articles analyzed the reproductive number with empirical data (Table 1.3). 
Seventeen articles reported explicit estimates, with five estimating the effective 
reproductive number and twelve estimating the basic reproductive number. The majority 
of these articles used mathematical compartmental models with different variations in 
structure and parameterization to address issues such as seasonality [29], the effect of age 
[30,31] , and HIV-TB co-epidemics [8].  
 
Two articles [7,32] used the Wells-Riley model or a modified version of the model. In 
these models, the reproductive number was expressed as a function of infection risk, 
which was further expressed as proportionate to environmental factors such as the 
number of infectious people in a given space, per-person breathing rate and inversely 
proportionate to germ-free ventilation rate. One article derived the reproductive number 
as a function of the transmission index— defined as the ratio of the number of secondary 
cases to the sum of the number of source cases (infectors) and non-clustered cases where 
clusters are defined as groups of patients that had isolates with identical fingerprints [33]. 
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The largest reproductive number (effective) was estimated in [34] using the Chinese 
Centre for Disease Control and Prevention (CDC) data from 2005-2012, where the 
annual reproductive number ranged between 3.33 and 4.30 for years 2005-2012 in China. 
The lowest (effective) reproductive number was estimated at 0.24 (95% CI:0.17-0.31) 
using RFLP data in San Francisco, USA from 1991 to 1996 [35]. Vynnycky and Fine 
[31] in 1998 used an age-structured mathematical model and estimated the effective 
reproductive number to be around 1 from 1900-1950 in England and Wales; the basic 
reproductive number was estimated to have declined from about 3 in 1900 to 2 by 1950, 
and first fell below 1 in about 1960. The assumptions of these models are listed in Table 
1.3.  
 
One article defined the reproductive number as the number of secondary infections 
caused by an infectious case [7]. As only a fraction of the infected people develop active 
disease, the estimated reproductive number was larger than those in the other papers. The 
median of the reproductive number in this article ranged from 14 to 45 as exposure time 
increased from 1 month to 5 months. 
 
Twenty-nine articles analyzed the reproductive number through simulation based on a 
mathematical modeling framework (Table 1.4). These articles all used mathematical 
compartmental models with different variations to address issues such as reinfection [36], 
the interaction between HIV and TB [37], and drug-resistant and drug-sensitive TB [38]. 
The majority of them focused on studying the effect of these issues on TB transmission 
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dynamics through simulations that were not based on a specific population. In this case, 
parameters for the model were based on estimates from studies performed in diverse 
settings or sampled over a range of feasible values. The analytical expression of the basic 
reproductive number was derived to study the disease-free equilibrium and endemic-
persistent state of TB in these papers. Five articles [9,37–40] included drug-resistant TB 
cases as a compartment and four articles [36,41–43] included HIV+ TB cases as a 
compartment. 
 
1.2.3 Discussion 
 
We found very few publications that reported estimates for the SI of TB. Estimates of the 
reproductive number were limited to seven countries, with the majority of the 
publications using mathematical compartmental models that did not base estimates on 
actual data. This indicates a need for a better understanding of these crucial parameters of 
TB transmission, which can help inform public health decisions in order to reach the 
WHO’s End TB goals [1] of reducing TB deaths by 95% and incident cases by 90% by 
2035.  
 
Serial interval 
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We found only five articles that discussed the estimation of the SI for TB and presented 
explicit estimates. ten Asbroek [22] estimated the SI over four years as a geometric mean 
of 0.57 years (95% CI:0.44-0.73). Using the same method over a longer study period (15 
years compared to four years in [22]), the estimated median was 1.44 years, which is 
comparable to the median serial interval of 1.65 years in [24] with a four-year study 
period. This indicates that the study period could potentially bias the SI estimates, even 
though the method in [22] corrected for the underrepresentation of longer SIs. In contrast 
with other infectious diseases that progress much faster and have SIs measured in days, 
the SI of TB can be weeks, years and even decades [44]. This unique feature of TB 
makes it difficult to obtain an unbiased estimate of the SI as lengthy follow-up is required 
to observe the long period between presence of symptoms of the infector and the infected 
person. Additionally, uncertainty regarding the presence and impact of multiple infection 
events further complicates the observation of this interval. Currently, the most common 
way of monitoring TB is by looking at annual incidence rates in studies that are often no 
longer than five years [45,46]. This creates two issues: right censoring as symptoms of 
the infected people can develop long after the end of studies, and interval censoring as the 
symptom onset time can fall during long intervals between two observed time points. 
Another issue is patients’ and doctors’ delay. Patients may not seek medical assistance 
immediately after symptoms develop and diagnosis may require lab processing time 
which causes delay in establishing the diagnosis [22], creating a left censoring issue. 
Survival analysis techniques can be considered to address these issues but may need 
substantial modification. Further ambiguity exists due to the inconsistent availability of 
genetic typing of strains to link cases, and the further uncertainty about how to best link 
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strains when genetic information is available, as such information may not account for 
mutation rate, or infection with multiple bacterial strains.  
 
Reproductive number 
 
The majority of the articles used mathematical compartmental models (a brief 
introduction can be found in the appendix) to describe the transmission dynamics of TB. 
These models have been widely used to understand the dynamics of infectious diseases 
including SARS, influenza and TB, and they either use empirical data to estimate the 
parameters in the model or are based on simulation. 
 
The compartmental models using empirical data are distinguished from simulation-based 
models in two key ways. First, empirical models use data to estimate some of the model 
parameters, while others are taken directly from the literature or assumed. Simulation-
based models do not use empirical data to parameterize the models. For example, in [47] 
where empirical data was used, the mortality rate due to drug susceptible TB was 
estimated from Taiwanese Centre of Disease Control data and the effective contact rate 
for TB was estimated based on the literature; in [48] where simulation was used, the 
recruitment rate was taken from the literature and awareness rate of TB was estimated 
from data.  
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A second distinction between models based on empirical data and simulation-based 
models is that the former often report explicit estimates of the reproductive number for a 
specific region, while the latter usually focus on studying the impact of a certain feature 
on TB transmission dynamics. For example, in [49] where empirical data was used, the 
reproductive number was reported for India overall and by regions; in [38] where a 
simulation-based approach was used, the impact of drug-sensitive and drug-susceptible 
strains mixed together on TB transmission dynamics was studied. 
 
In developed countries, the reproductive number was sometimes estimated to be well 
below 1: for example, 0.55 in the USA from 1930 to 1995 [50] and 0.26 in the 
Netherlands from 1993 to 1995 [33]. In developing countries, the reproductive number 
was as high as 4.3 in China in 2012 [34] and 3.55 in Southern India from 2004 to 2006. 
In the Netherlands, the reproductive number has been consistently estimated at well 
below one, ranging from 0.24 [35] to 0.48 [51].  
 
In both [26,27], the same dataset in San Francisco, USA in 1994 was used to estimate the 
effective reproductive number. The disparate estimates from these two papers were 
reconciled in [28] to an estimated effective reproductive number of approximately 2.1. 
This estimate contrasted with another estimate for the USA of 0.55 in [50] where the 
reproductive number was estimated using case rates of active TB in USA from 1955 to 
1994. In addition, Borgdorff [35] reported an effective reproductive number of 0.24 using 
RFLP data in San Francisco from 1991-1996. These different estimates from the same 
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country may be attributable to the difference in methods, the types of data analyzed, or 
may indicate that there was an expanding TB epidemic occurring in San Francisco in 
1994 concurrent with the HIV/AIDS epidemic (hence a reproductive number above 1) 
[28]. The San Francisco data contained genetic RFLP information and was analyzed with 
a likelihood-based method. The method in [50] used case rates and derived an analytic 
expression of the reproductive number based on such rates. Likely all three issues 
(different methods, type of data and setting) contributed to the discrepancy in the 
estimates. 
 
The analysis of the 1994 San Francisco data provides an interesting case study in the 
impact of different methodologies, since all three different estimates were obtained from 
the same dataset [25]. Further the analysis of data from 1991-1996 in San Francisco by 
Borgdorrff et al. [33] provides a dramatically smaller estimate, perhaps due to the 
inclusions of non-epidemic years in the analysis. Without consistent approaches to 
estimation and some degree of standardization in data formats for this activity, reliable 
estimates that can be compared across regions will be elusive.   
 
Similar to the more statistical analysis of the San Francisco data, we observe that 
mathematical models lead to inconsistent results, at least partially attributable to the 
varying assumptions they make in their structure and parameterization. For example, 
even though both [34] and [47] used mathematical compartmental models with different 
variations for similar regions (China and Taiwan), they have quite different estimates: 
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between 3.3 and 4.3 in China from 2005 to 2012 as compared to 0.9 for drug-sensitive 
TB, around 0.38 for multidrug-resistant TB (defined as a TB strain resistant to at least 
isoniazid and rifampicin) in Taiwan from 2005 to 2010. Both articles used incidence data 
from Chinese and Taiwanese CDC but formulated the compartments in the models 
differently. In [34], compartments “exposed”, “infectious and hospitalized” and 
“infectious but not hospitalized” were included; in [47], compartments “latent”, 
“infected” were used for two sub-populations: drug-sensitive and multidrug-resistant. The 
model parameters were also differently specified: in [34], some parameters were assumed 
while others were estimated using minimum sum of square; in [47], some parameters 
were given a probabilistic distribution and estimated with a root mean squared error 
method while others were assumed. The difference between the estimated reproductive 
numbers produced from these two modeling exercises is striking, as the two regions and 
populations are quite comparable in terms of demographics, economic status and access 
to health care. One could similarly contrast the modeling approaches and estimates 
obtained in [52] and [29], two other studies from China and Taiwan from similar time 
periods that produced different estimates. The differing model structures, as well as the 
parameter estimates, including the recruitment rate, incidence rate, and mortality rate, 
likely drive these observed differences. It is difficult to say which model might be a more 
accurate reflection of reality. 
 
The example above illustrates the challenges of interpreting and using mathematical 
models for estimation of the reproductive number. However, most estimates to date make 
use of this approach. One shortcoming of these models is that they require assumptions 
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about parameter values that may be difficult to estimate, such as the transmission rate, the 
treatment rate, and the recovery rate, which are often unobservable and not reliably 
estimated. As a result, most of the articles assume values for the parameters in the model 
based on evidence in the published literature, where it exists, sometimes without 
measures of uncertainty (e.g. standard errors). Model structure also varies substantially 
from study to study, with no generally agreed upon approach to model TB and estimate 
parameters. The generalizability of the estimates and approaches to estimation presented 
is therefore questionable. We believe that it is important to develop analytic, data-driven 
tools to estimate the reproductive number that require minimal assumptions. 
 
 
Our review is subject to a number of limitations. It is possible that some useful papers 
could have been excluded due to our selection of search terms and our inclusion of 
reports in only English. These limitations are difficult to avoid in systematic reviews, in 
which the potential for increased yield from a wider search must be weighed against the 
increased feasibility of a tighter search. Additionally, our query was limited to searching 
in abstracts and titles, making it possible that we excluded articles where the keywords 
only appear in the text [23]. 
  
In conclusion, a limited number of studies have yielded explicit estimates for the serial 
interval and reproductive number of TB. When estimating the SI, it is difficult to observe 
the symptom onset of the infector and infected person with precision. Estimates of the 
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reproductive number were limited geographically (Figure 1.5) with estimates only 
available for seven countries. Settings with high TB burdens, especially high drug-
resistant TB burdens such as the former Soviet Union [53] are not included in these 
papers. In addition, there was only one estimate from a high TB and high HIV burden 
country [54]. The lack of estimates could be because incidence and mortality rates are 
currently used to monitor TB control. These rates are not suitable for monitoring 
transmission; reductions in mortality could be attributed to improvements in treatment 
outcomes rather than any change in transmission and, due to the long incubation period 
of TB, changes in transmission could take years to impact incidence rates. In contrast, the 
reproductive number can provide a direct estimate of TB transmission itself. Most studies 
used mathematical models with various assumed model structures and parameters, 
making it difficult to compare the estimates and draw useful conclusions about the TB 
transmission dynamics by evaluating the reproductive number.  
 
The WHO End TB goals [1] include reducing TB deaths by 95% and incident cases by 
90% by 2035. To achieve these goals, it is necessary to obtain improved estimates of the 
reproductive number and the SI as they can be used for monitoring and evaluating the 
effect of interventions on TB transmission. For example, the serial interval of TB can be 
used to determine how long one must monitor contacts of an infectious TB case to see if 
they will develop symptoms [55]. The effective reproductive number can be used to 
monitor the efficacy of interventions in reducing transmission. As interventions decrease 
transmission, estimates of the reproductive number should correspondingly decrease; in 
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particular, if the reproductive number can be maintained below one, the disease can 
potentially be eliminated. 
 
The limited number of articles that we found, and the lack of geographic representation, 
demonstrate a substantial gap in our understanding of these crucial parameters of TB 
transmission in diverse settings. 
 
 
Figure 1. 1: Important infectious disease intervals.  
The time between a and c is the serial interval; the time between b and c is the incubation 
period. 
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Figure 1. 2: Flow diagram of articles included in the search of estimates of the serial 
interval. 
  20 
 
Figure 1. 3: Flow diagram of articles included in the search of estimates of the 
reproductive number. 
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Figure 1. 4: Reproductive number from studies with explicit R estimate from empirical 
data. 
 
Notes: (1) The range is for years 2005-2012, with the reproductive number estimated at 
3.33, 3.72, 3.38, 3.97, 4.29, 3.32, 3.92 and 4.30, respectively; (2) For each location, the 
first R corresponds to drug-sensitive population and the second correspond to drug-
resistant population; (3) R estimated for 35 states and union territories of India with 
estimates ranging from 0.72 to 0.98; 0.92 is the overall estimate for India; (4) For each 
location, the first R corresponds to drug-sensitive population and the second correspond 
to drug-resistant population; (5) Bordgorff in [35, 56, 58] estimated the reproductive 
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number for the Nethelands from 1993 to 2007 at around 0.26 with lower bound of the 
95% CI around 0.20 and upper bound around 0.32; (6) Broken lines indicate range; solid 
lines indicate 95% confidence interval; (7) Vynnycky [23] in 1998 estimated the basic 
reproductive number to decline from about 3 in 1900 to 2 in 1950 and to below 1 in about 
1960 for England and Wales, which is not included in this graph. 
 
 
Figure 1. 5: Shaded areas and stars indicate countries and cities with reproductive number 
estimates.  
Multiple estimates: China, Taiwan, USA, India; one estimate: Ukraine, the Netherlands, 
South Africa, the UK. *indicates San Francisco corresponding to data used in [28, 29, 30] 
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Table 1. 1: Estimates of the Serial Interval 
 
Name of 1st 
author, 
publication 
year 
Objective Method Assumptions Estimated 
serial interval  
Leung [20], 
2013 
Study 
household 
transmission of 
MDR-TB 
Data on all 
MDR-TB in 
Hong Kong 
1997-2006. Did 
contact 
investigations 
and DNA 
fingerprinting 
and linked 
index to 
secondary cases 
No censoring 
in this 
estimate, not 
clear how long 
people were 
followed up for 
1.4 (0.4-5.2) 
years 
(median) 
Vynnycky 
[44], 2000 
 
Demonstrate 
how the 
lifetime risk of 
An age-
dependent 
Assumed 
values for 
model input 
Estimated as 
dependent on 
age of 
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disease, the 
incubation 
period and the 
serial interval 
changed  
compartmental 
model 
parameters 
such as the 
annual risk of 
infection 
infection and 
summarized 
as frequency 
distributions 
ten Asbroek 
[22], 1999 
To determine 
the  
serial interval 
and incubation 
period of 
tuberculosis 
within 4 years 
of transmission 
Descriptive 
approach on 
RFLP data 
(used to link 
infectors and 
infected people) 
One source of 
infection for 
each infected 
cluster 
0.57 years 
(95% CI: 
0.44-0.73) 
Borgdorff 
[23], 2011 
Same as [24] Same as [24] NA Median: 1.44 
years (95% 
CI: 1.29-1.63) 
Brooks-
Pollock 
[24], 2011 
Estimate the 
relative 
contributions of 
household and 
community 
transmission, 
Descriptive 
approach for 
the serial 
interval 
All members 
of the study 
cohort have 
been exposed 
to TB by living 
with someone 
Mean serial 
interval: 3.5 
years; median 
serial interval 
1.65 years 
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the serial 
interval, and 
the immunity 
afforded by a 
previous 
TB infection 
with active 
disease 
 
Table 1. 2: Estimates of the Reproduction Number Using Approximate Bayesian 
Computation and Exact Likelihood Methods 
 (All methods used data from San Francisco on cases reported in 1994) 
 
Name of 1st 
author, 
publication 
year 
Objective Method Assumptions Estimated 
reproductive 
number (95% 
credible 
interval) 
Tanaka 
[26], 2006 
Estimate TB 
transmission 
parameters: net 
transmission 
Approximate 
Bayesian 
computation 
Constant supply 
of susceptible 
people; all 
genotypes are 
3.4 (1.4-79.7) 
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rate, doubling 
time and 
reproductive 
number 
selectively 
neutral; mutation 
and transmission 
are independent; 
infinite alleles; 
epidemic 
spreads until N 
individuals are 
infected 
Stadler 
[27], 2011 
Estimate TB 
transmission 
parameters: net 
transmission 
rate and 
reproductive 
number 
Exact 
likelihood 
Constant birth-
death rate; 
infinite alleles; 
epidemic started 
at a random time 
in the past; an 
isolate is 
sampled from an 
individual with 
probability p 
1.02 (1.01-
1.04) 
Aandahl 
[28], 2014 
Reconcile the 
different 
Improved the 
method in [26] 
by specifying 
Fixed mutation 
rate; used 
Gaussian prior 
1) 2.1 (1.54-2.66) 
in [26] 
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estimates in 
[26] and [27] 
informative 
priors; 
improved 
convergence 
performance of 
the MCMC 
sampler in [27] 
for the 
death/recovery 
rate 
2) 2.05 (1.55-
2.63) in [27] 
 
 
Table 1. 3: Estimates of the Reproductive Number from Mathematical Models with 
Empirical Data 
Name of 1st 
author, 
year;  
location and 
time; 
data type 
Objective Methods Assumptions Reproductive 
number type; 
estimated 
reproductive 
number 
Zhao [52], 
2017; 
China 2005-
2016, 
CDC 
To investigate 
the impact of 
age on TB 
transmission 
SEIR model 
with age 
structure; use 
least squares 
to get 
Although the 
susceptible 
compartment 
was stratified by 
age, the other 
Basic; 
1.786 (95% 
CI: 1.775 - 
1.796) 
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parameters 
that align with 
TB data in 
China; use 
latin 
hypercube 
sampling to 
get CI 
compartments 
were not age-
stratified thus 
assuming no 
difference in age 
for those 
compartments 
Liu [56], 
2017; 
China, 
2004-2014; 
annual 
TB case 
data 
To use 
modeling to 
investigate the 
impact of 
different 
vaccination 
strategies 
(constant or 
pulse BCG) 
on TB 
transmission 
Compartment
al models 
with 
vaccination 
compartments 
Assumptions 
made for all 
parameter values 
Basic; 1.19 
Yang [57], 
2016; 
Shaanxi, 
Study the 
seasonality 
impact on TB 
A seasonality 
TB 
compartmenta
Parameter values 
for recruitment 
rate, natural 
Basic; 
dependent on 
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China, 
2004-2012; 
Notifiable 
active TB 
cases by 
month 
transmission 
dynamics 
l model: 
subjects either 
entered latent 
or diseased 
compartment; 
contact rate, 
reactivation 
rate and 
disease-
induced death 
rate are 
periodic 
continuous 
functions 
death rate, 
recovery rate  
parameter 
values 
Nebenzahl-
Guimaraes 
[58], 2015; 
the 
Netherlands, 
1993-2011; 
surveillance 
and RFLP 
Determine if 
mycobacterial 
lineages affect 
infection risk, 
clustering, 
and disease 
progression 
among 
Descriptive 
and regression 
approach; 
DNA 
fingerprinting 
to link cases 
All secondary 
cases captured in 
surveillance 
data; genetic 
matching 
accurately 
reflects 
Effective; 
range: 0.17-
1.04 
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Mycobacteriu
m 
tuberculosis 
cases 
transmission 
patterns 
Narula [49], 
2015; India, 
2006-2011; 
central TB 
division 
data 
Estimate basic 
R0 for TB 
Compartment
al model with 
Bayesian 
melding 
technique to 
estimate 
parameters; 
Susceptible, 
latent, 
infected 
compartments 
instead of SIR 
Some parameter 
values assumed 
with reference in 
the differential 
equations 
Basic;  
0.92, 
averaged for 
India overall 
with range 
0.72-0.98 
Zhang [34], 
2015; 
China, 
2005-2012; 
CDC 
Estimate 
effective R0 
of TB by year 
Compartment
al model 
adding 
hospitalized 
compartment; 
Chi-Square 
An upper bound 
for number of 
initially 
susceptible 
people, natural 
death rate, initial 
Effective; 
range from 
3.318-4.302 
from year 
2005 to 2012 
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test for 
optimal 
parameters  
number of latent 
individuals 
Ypma [51], 
2013; the 
Netherlands, 
1993-2007, 
RFLP 
Explore the 
high 
heterogeneity 
in the number 
of secondary 
cases caused 
per infectious 
individual for 
TB 
Model 
“superspreadi
ng” parameter 
as a negative 
binomial 
distribution 
Immigrants who 
have been in the 
country for less 
than six months 
at diagnosis are 
index cases 
themselves 
Effective; 
0.48 (95% CI 
0.44-0.59) 
Andrews 
[32], 2012; 
Cape Town, 
South 
Africa, 
2011; 
national 
survey data 
Estimate risk 
of TB 
transmission 
on 3 modes of 
public transit 
Modified 
Wells-Riley 
model for 
airborne 
disease 
transmission 
Duration of 
infectiousness of 
1 year; used TB 
and HIV 
parameters from 
studies in the 
same area; 
natural history 
parameters from 
literature 
Basic; 
dependent on 
duration of 
infectiousness 
and frequency 
of transit 
usage 
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Okuonghae 
[48], 2011; 
Nigeria 
2008; 
survey data 
Assess how 
control 
strategies on 
addressing TB 
transmission 
parameters 
can minimize 
incidence 
Compartment
al model 
adding 
compartments 
of disease 
awareness 
level, 
identified 
infectiousness 
Model parameter 
values such as 
recruitment rate, 
recovery rate 
from literature  
Basic; 
dependent on 
parameter 
values 
Liao [47], 
2012; 
Taiwan, 
2005-2010; 
CDC data 
Estimate 
MDR-TB 
infection risk  
Mathematical 
probabilistic 
two-strain 
model with 
compartments 
for drug-
sensitive and 
drug-resistant 
subjects; 
dose-response 
model for 
relationship 
between R0 
Some model 
parameter values 
from data, some 
from literature; 
assumed 0.99 of 
people latently 
infected were 
drug sensitive 
and 0.01 were 
drug resistant 
Basic; 
Hwalien 
County: 0.89 
(95% CI: 
0.23-2.17) for 
drug 
sensitive; 0.38 
(95% CI: 
0.05-1.30) for 
multi-drug 
resistant; 
Taitung 
County: 0.94 
  33 
and total 
proportion of 
infected 
population  
(95% CI: 
0.24-2.28) for 
drug 
sensitive; 0.38 
(95% CI: 
0.05-1.33) for 
multi-drug 
resistant; 
Pingtung 
County: 0.85 
(95% CI: 
0.21-2.08) for 
drug 
sensitive; 0.34 
(95% CI: 
0.04-1.13) for 
multi-drug 
resistant; 
Taipei City: 
0.84 (95% CI: 
0.21-2.00) for 
drug 
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sensitive; 0.30 
(95% CI: 
0.04-0.97) for 
multi-drug 
resistant; 
 
 
Liao [29], 
2012; 
Taiwan, 
2004-2008; 
CDC data 
Examine TB 
population 
dynamics and 
assess 
potential 
infection risk 
Compartment
al model with 
susceptible, 
latently 
infected, 
infectious, 
non-infectious 
and recovered 
compartments
; incorporated 
reactivation, 
relapse and 
reinfection 
Some parameter 
values taken 
from literature, 
some estimated 
from data 
Basic; 
Highest R0 
total in 
Hwalien: 1.65 
with 95th 
percentile 
range 0.45-
6.45; Taipei 
lowest at 1.5 
(0.45-4.98); 
Taitung: 1.72; 
Pingtung: 
1.65 
Liu [59], 
2012; China 
Incorporate 
migration to 
SEIR 
compartments 
Model 
parameters 
Basic;  
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2000-2008; 
National 
Bureau of 
Statistics 
data 
study TB 
transmission 
for rural 
residents, 
migrant 
workers and 
urban 
population 
calculated from 
website data; 
migration rates  
no explicit 
estimate 
Borgdorff 
[60], 2010; 
the 
Netherlands, 
1993-2007, 
RFLP data 
Determine to 
what extent 
tuberculosis 
trends in the 
Netherlands 
depend on 
secular trend, 
immigration 
and recent 
transmission 
DNA 
fingerprinting 
to link cases 
All secondary 
cases captured in 
surveillance 
data; genetic 
matching 
accurately 
reflects 
transmission 
patterns 
Basic; 
0.24 (95% CI 
0.21-0.26) 
Liu [61], 
2010; 
China, 
2005-2008; 
Ministry of 
Health data 
Develop a 
model 
incorporating 
seasonality 
and define 
basic 
Used periodic 
infection rate 
and 
reactivation 
rate to 
incorporate 
Parameters such 
as recruitment 
rate, natural 
death rate were 
assumed to be 
constants; some 
Basic; 
dependent on 
parameter 
values with 
range 0.4-2.6 
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reproduction 
ratio 
seasonality in 
the 
compartmenta
l model; 
considered 
fast and slow 
progression  
parameter values 
assumed and 
some taken from 
literature 
Brooks-
Pollock 
[30], 2010; 
Ukraine, 
1959 and 
2006; 
Mortality 
data 
Explore the 
effect of age 
structure on 
TB infection 
and disease 
prevalence, 
basic 
reproductive 
number and 
impact of 
intervention 
Basic SEIR 
mathematical 
model with 
assumptions 
about 
survivorship  
A survivorship 
function which 
could be 
described in 
terms of age and 
life expectancy 
Basic; 
dependent on 
progression 
rate with 
range 0-0.85 
Basu [54], 
2009; South 
Africa; 
Extensively 
Model XDR-
TB 
transmission 
dynamics 
Model XDR-
TB 
incorporating 
the existing 
Even mixing of 
air; range of key 
parameters in the 
model 
Effective; 
1.97, range 
0.7-4.6; 
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drug-
resistant TB 
data (XDR-
TB)  
XDR 
detection rate 
and treatment 
system 
1.23, range 
0.4-3.1 when 
combining 
screening and 
therapy; 
1.38, range 
0.6-3.3 with 
South African 
strategic plan 
alone. 
 
Furuya [7], 
2008; Japan 
2000-2005; 
exposure 
data 
Quantify the 
risk of TB 
infection in an 
internet café 
where people 
without 
homes stayed 
overnight 
Wells-Riley 
model to 
estimate the 
reproductive 
number 
Patients stayed 
in a confined 
space for 150 
days; some 
values in the 
Wells-Riley 
equation 
assumed, others 
from literature 
Estimated as a 
function of 
the exposure 
period; 
dependent on 
exposure 
period 
Long [8], 
2008; 
Model HIV-
TB co-
First model: 
susceptibility 
A linear 
relationship 
Basic; 
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Southern 
India, 2004-
2006; HIV-
TB data 
epidemics and 
explore 
hypothetical 
treatment 
effect 
to either or 
both diseases 
compartments
; second 
model: 
SII*SEI  
between 
treatment levels 
and the 
associated 
parameters; 
model 
parameters from 
literature 
R=3.55 when 
no active 
treatment for 
TB 
Borgdorff 
[62], 2005; 
the 
Netherlands, 
1995-2002; 
RFLP data 
Assess 
progress 
towards TB 
elimination  
 
DNA 
fingerprinting 
to link cases; 
survival 
analysis 
All secondary 
cases captured in 
surveillance 
data; genetic 
matching 
accurately 
reflects 
transmission 
patterns 
Basic;  
Dutch index 
cases: 0.23, 
non-Dutch 
index cases: 
0.25 
 
Borgdorff 
[35], 2000; 
San 
Francisco, 
USA, 1991-
Determine 
tuberculosis 
transmission 
dynamics in 
San Francisco 
Define 
effective 
reproductive 
number as a 
function of 
Each cluster 
originates from a 
single source 
case in the 
database; either 
Effective; 
0.24 (95% CI: 
0.17-0.31) 
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1996; RFLP 
data 
and its 
association 
with country 
of birth and 
ethnicity 
transmission 
index, which 
is a function 
of number of 
secondary 
cases and 
potential 
source cases 
in a given 
subgroup 
the first case of a 
cluster was its 
source case, or 
that the 
probability of 
being a source 
case declined 
exponentially 
over time by 
0.77% per day 
Davidow 
[63], 2000; 
New York 
City, 1989-
1993; 
surveillance 
data 
Evaluate the 
importance of 
recent M. 
tuberculosis 
transmission 
Estimated # of 
TB infectious 
cases 1 year 
ago and 
computed 
short-term 
R0; R0= the 
average # of 
new 
infections 
caused by 
each case per 
Some clinical 
assumptions; 
parameter values 
in equation taken 
from literature or 
calculated from 
neighborhood-
specific data 
Short-term; 
no explicit 
estimates; 
focused on 
percentage of 
TB cases due 
to infection 1 
year ago 
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year of 
infectiousness
*the average 
duration of 
infectiousness
*the 
probability of 
progressing to 
active TB 
within 1 year 
after infection 
 
 
Vynnycky 
[31], 1998; 
England and 
Wales, 
1900; 
surveillance 
data and 
mortality 
rates 
Describe 
transmission 
dynamics of 
all forms of 
pulmonary 
TB 
Age-
structured 
mathematical 
model with 
compartments 
for 
endogenous 
and 
General 
relationship 
between: 1st 
primary episode 
and age at 
infection, risk of 
exogenous 
disease and age 
at reinfection, 
Effective; 
net R at about 
1 from 1900-
1950; basic 
R0 declined 
from about 3 
in 1900, 
reached 2 by 
1950, and first 
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exogenous 
diseases 
endogenous 
disease and 
current age; risk 
of reinfection 
and 1st infection 
are identical; 
parameter values 
from literature  
fell below 1 in 
about 1960 
Salpeter 
[50], 1998; 
USA, 1930-
1995; case 
rates data 
Estimate time 
delay from 
infection to 
disease and R 
Estimate R as 
a function of 
case rate and 
the shape of 
the delay 
function 
R and case rate 
constant with 
calendar time t; 
incidence rate of 
latent infection is 
independent of 
the age 
Effective; 
0.55, range 
0.4-0.7 in 
sensitivity 
analysis 
Borgdorff 
[33], 1998; 
the 
Netherlands, 
1993-1995, 
RFLP data 
Quantifying 
transmission 
of TB 
between and 
within 
nationalities 
Effective R0 
estimated as a 
function of 
transmission 
index 
Probability of a 
patient being the 
source of a 
cluster was 
proportional to 
the incidence 
rate 
Effective; 
0.26, 95% CI: 
(0.20-0.32); 
also estimated 
for different 
nationalities 
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of potential 
sources times the 
probability that a 
potential source 
would give rise 
to a cluster 
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Table 1. 4:  Estimates of the Reproductive Number from Mathematical Models based on 
Simulation 
Name of 1st 
author, 
publication 
year 
Objective Methods, 
setting 
Assumptions Reproductive 
number type; 
estimated R0 
Ren [64], 
2017 
Develop SEIR 
model for 
imperfect 
treatment with 
age-dependent 
latency and 
relapse 
SEIR model TB infectious 
in latent 
period; age-
dependence 
Basic; 
dependent on 
parameters 
Jabbari 
[65], 2016 
To set up a 
model that 
can examine 
two TB 
strains (DS 
and DR) with 
Mathematica
l 
compartment
al model 
with 
compartment
The drug-
sensitive 
strain will not 
play a role in 
the process of 
exogenous 
Basic; 
dependent on 
parameters 
  44 
multiple latent 
stages 
s for latency 
stages 
reinfection for 
the 
drug-resistant 
strain 
Okuonghae[
66], 2016 
Study the 
effects 
of additional 
heterogeneitie
s from the 
level of TB 
awareness on 
TB 
transmission 
dynamics and 
case detection 
rate 
 
Expanding 
[49] by 
dividing both 
susceptible 
and latently 
infected 
compartment 
by level of 
TB 
awareness 
Reasonable 
values and 
bounds for 
parameters 
such as 
transmission 
rate, recovery 
rate from 
literature 
Effective; 
dependent on 
parameters such 
as active case 
finding rate and 
treatment rate 
Liu [67], 
2014 
Evaluate 
effect of 
treatment for 
TB 
Compartmen
tal model 
with 
treatment and 
two latent 
Once the 
treatment of 
active TB 
cases is 
Basic; 
dependent on 
transmission 
coefficients 
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periods 
incorporated 
interrupted, 
there 
is no more 
treatment; 
specified 
model 
parameter 
values and 
their 
relationship 
with one 
another 
Silva [68], 
2013 
Study optimal 
strategies 
for the 
controlling 
active TB 
infectious 
and persistent 
latent 
individuals 
 
Compartmen
tal model 
considering 
reinfection 
and post-
exposure 
interventions 
with the 
addition of 
early latent 
Parameter 
values taken 
from literature 
Basic; 
dependent on 
transmission 
coefficient 
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and 
persistent 
latent 
compartment
s 
Hu [69], 
2012 
Study the 
threshold 
dynamics of 
TB 
Compartmen
tal model 
with periodic 
functions for 
reactivation 
rate and 
infection 
rate; include 
additional 
compartment 
for treated 
people that 
do not return 
to the 
hospital for 
examination 
NA Basic; 
dependent on 
transmission 
coefficient 
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Emvudu 
[70], 2011 
Address the 
problem of 
optimal 
control for TB 
transmission 
dynamics 
Compartmen
tal model 
with an 
additional 
compartment 
for loss to 
follow-up 
Half of the 
parameter 
values were 
assumed; 
others taken 
from 
Cameroon 
literature 
Basic; 
dependent on 
parameters such 
as transmission 
rate 
Sergeev 
[38], 2011 
How drug-
sensitive and 
drug-
resistance 
strains mixed 
together can 
impacts long-
term TB 
dynamics 
Compartmen
tal with the 3 
compartment
s for both 
latent and 
infected: 
drug-
resistant, 
drug 
sensitive and 
mixed strains 
Reasonable 
values for 
many 
parameters; 
few data exist 
to inform 
model 
parameters 
Basic; 
dependent on 
model 
parameters; 
estimated for 
drug-resistant, 
drug-sensitive 
and mixed 
strains 
Roeger 
[41], 2009 
Model TB and 
HIV co-
infection 
Compartmen
tal model for 
joint 
Probability of 
infection is 
the same for 
Overall R0 as 
the max of R0 
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dynamics of 
TB and HIV 
and compute 
independent 
reproductive 
numbers for 
the two 
diseases 
those treated 
with TB and 
those 
susceptible; 
assumed 
relationship 
among model 
parameters 
for TB and 
HIV;  
dependent on 
model 
parameters  
Gerberry 
[71], 2009 
Study the 
trade-off 
between BCG 
and detection, 
treatment of 
TB 
Compartmen
tal model 
with 
additional 
compartment
s for latently 
infected and 
unvaccinated
, latently 
infected and 
vaccinated; 
establish 
thresholds 
for basic R0  
Throughout 
the duration 
of the 
vaccine’s 
efficacy, 
latent TB 
completely 
undetectable 
Basic; 
dependent on 
model 
parameters 
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Bhunu [72], 
2009 
Model 
HIV/AIDS 
and TB 
coinfection 
Compartmen
tal model for 
TB, HIV 
separately 
without 
intervention; 
full model 
with 
intervention  
Parameter 
values from 
Central 
Statistics 
Office of 
Zimbabwe 
and literature; 
relationship 
amongst 
parameters in 
the model 
Basic; 
dependent on 
model 
parameters 
Bhunu [73], 
2008 
Model the 
effect of pre-
exposure and 
post-exposure 
vaccines  
Compartmen
tal model 
with 
additional 
compartment
s for 
susceptible 
(vaccinated 
or not) and 
latent 
(history of 
Homogeneous 
mixing; 
recovered 
people would 
not develop 
disease from 
reinfection, 
but could be 
re-infected; 
parameter 
values taken 
Basic; 
dependent on 
model 
parameters  
  50 
vaccine or 
not) 
from Central 
Statistics 
Office and 
literature 
Sharomi 
[37], 2008 
Address the 
interaction 
between HIV 
and TB 
TB-only, 
HIV-only 
and full 
model 
analyzed 
with both 
susceptible 
and latent 
compartment
s divided 
according to 
TB and HIV 
status 
Dually 
infected 
people could 
not transmit 
both diseases; 
some 
parameters 
taken from 
literature, 
others 
assumed 
Basic; 
dependent on 
model 
parameters 
McCluskey 
[74], 2006 
Address 
global 
stability of 
high 
Use 
Lyapunov 
function to 
demonstrate 
 Basic;  
no explicit 
estimate 
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dimensional 
TB model 
the stability 
of the 
endemic 
equilibria in 
mathematical 
models for 
TB: SEIR, 
SEIS and 
SIR; fast and 
slow 
progression 
incorporated 
Martcheva 
[75], 2003 
Address the 
issue of an 
infected 
person being 
subject to 
further 
contacts with 
infectious 
individuals—
Subdivide 
the 
latent stage 
into one 
where the 
disease 
progresses 
and one 
where the 
disease 
Relationship 
among model 
parameters 
Basic; 
no explicit 
estimate 
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“super 
infection” 
development 
is on hold 
Aparicio 
[76], 2000 
Express basic 
R0 as a 
function of 
cluster size 
Divide 
individuals 
into either 
active 
clusters or 
otherwise 
Homogeneous 
mixing 
Basic; 
no explicit 
estimate; 
expressed as a 
function of 
household size 
Feng [36], 
2000 
Examine how 
exogenous 
reinfection 
changes the 
TB 
transmission 
dynamics 
Include 
additional 
parameters in 
the 
mathematical 
model to 
model 
exogenous 
reinfection 
Constant per 
capita 
removal rate 
to focus on 
the role of 
reinfection 
Basic; 
no explicit 
estimate; 
analytical 
expression 
Beatriz 
[77], 2000 
Assess the 
effects of 
heterogeneous 
infectivity 
Divide 
infective 
period into k 
stages  
Homogenous 
mixing; 
bilinear 
incidence rate 
Basic; 
no explicit 
estimate; 
analytical 
expression 
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Castillo-
Chavez 
[78], 1998 
Use an age-
structure 
model to 
study the 
dynamics of 
TB 
Use age-
specific 
parameters in 
the 
compartment
al model; 
transmission 
dynamics 
studied for 
with and 
without 
vaccine 
Mixing 
between 
individuals is 
proportional 
to their age-
dependent 
activity level; 
disease-
induced death 
rate neglected 
Net and basic; 
no explicit 
estimate; 
analytical 
expression 
Lietman 
[79], 1997 
Test the 
hypothesis 
that exposure 
to TB leads to 
disappearance 
of leprosy 
Add in 
leprosy 
compartment 
in the 
mathematical 
model 
Cross-
immunity is 
symmetric: 
same 
immunity for 
TB and 
leprosy 
Basic; 
dependent on 
R0 of leprosy 
and cross-
protection rate 
Sanchez 
[80], 1997 
Evaluate the 
effects of 
parameter 
Latin 
hypercube 
sampling 
Range for 
parameters in 
the 
Sum of R0 for 
fast, slow and 
relapse; 
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estimation 
uncertainty 
on the value 
of Ro 
used on 
parameters in 
the 
compartment
al model in 
Blower [80] 
to evaluate 
uncertainty 
of R0 
compartmenta
l model 
dependent on 
parameters in 
the model 
Gumel [9], 
2008 
Study the 
transmission 
dynamics of 
TB with 
multiple 
strains, in the 
presence of 
exogenous 
reinfection 
Included 
drug-
sensitive and 
resistant 
strains in the 
compartment
al model; 
exogenous 
reinfection 
incorporated 
Homogenous 
mixing 
Effective R0; 
dependent on 
parameters in 
the model 
Singer [81], 
2004 
Study the 
impact of 
different 
Compartmen
tal model for 
heterogeneou
Parameter 
range 
uniformly 
Basic; 
no explicit 
estimate 
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reinfection 
levels of 
latently 
infected 
individuals on 
TB 
transmission 
dynamics 
s population: 
one group 
more 
susceptible to 
infection 
than the 
other; 
distributed 
according to 
previous 
papers 
Trauer [42], 
2014 
Model TB 
transmission 
for highly 
endemic 
regions of the 
Asia-Pacific 
where HIV-
coinfection is 
low  
Compartmen
tal models 
with 
compartment
s for 
immunizatio
n, latency, 
reinfection, 
drug-
resistance, 
etc. 
Parameters 
fixed values 
according to 
papers and 
WHO 
Basic; 
dependent on 
parameters; 
computed as 
8.34 for drug-
susceptible and 
5.84 for drug-
resistant at 
baseline 
Dye [39], 
2000 
To establish 
criteria for 
Compartmen
tal models 
with 
Parameters 
calculated 
Basic; 
dependent on 
parameters; best 
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MDR-TB 
control 
compartment
s for drug-
susceptible, 
drug-
resistant, 
treatment 
failure, etc. 
from different 
populations 
estimated of the 
model 
parameters 
yielded R0=1.6 
(95% CI: 1.02-
2.67) 
Blower 
[82], 2004 
Track the 
emergence 
and evolution 
of multiple 
strains of 
drug-resistant 
TB 
Non-
compartment
al 
mathematical 
model. 
NA Basic; 
dependent on 
drug-
susceptibility of 
TB 
Blower 
[43], 1995 
Model the 
transmission 
dynamics of 
TB 
Compartmen
tal models 
with latently 
infected, 
infectious, 
non-
infectious, 
recovered 
Some model 
parameters 
assumed; 
some taken 
from 
references  
Basic; 
median of 4.47, 
range: 0.74-
18.58 
  57 
compartment
s. 
Blower 
[40], 1998 
Understand, 
predict and 
control TB 
Compartmen
tal models 
with drug-
sensitive and 
drug-
resistant 
compartment
s 
NA Basic; 
dependent on 
model 
parameters 
Aparicio 
[76],2009 
Evaluate 
homogeneous 
mixing and 
heterogeneous 
mixing 
models for TB 
Three types 
of 
compartment
al models: a 
standard 
incidence 
homogenous 
mixing 
mode; a 
heterogeneou
s mixing 
model; an 
Assumptions 
on model 
parameters 
Basic; 
dependent on 
model 
parameters 
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age-
structured 
model. 
 
 
 
  59 
 
1.3 Structure of Dissertation 
This dissertation focuses on addressing censoring issues in estimating the serial interval 
for TB. In Chapter 2, we evaluate via simulations the performance of a few different 
parametric approaches to estimate the SI under the assumption that all SIs are observed 
regardless of their length. In Chapter 3, we begin to relax the idealized assumptions in 
Chapter 2. As has been stated, household contact studies typically do not follow 
household contacts for more than 2-5 years [13,14]. Therefore, in this section, we follow 
the approach described in Chapter 2, but censor serial intervals according to different 
censoring mechanisms. We examine the impact of observing partial data on the 
performance of all the estimators, and propose to use cure models, first proposed by Boag 
[83] in 1949, in a Bayesian framework to estimate the serial interval for TB. In Chapter 4, 
we begin to address the coarseness in observing the symptom onset time of both the 
index cases and the household contacts, which are needed to calculate the SIs for the 
household contacts.  
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Chapter 2 Estimation of the serial interval under the idealized scenario of complete 
follow-up  
 
2.1 Introduction 
 
As was stated in the previous chapter, household contact studies are a common way to 
study transmission dynamics. In this setting, household contacts of an infectious TB case 
(index case) are typically followed for at least 2 years, with the assumption that most 
secondary cases will be observed during that time period. However, it could take years 
and even decades [18] for subjects to present with symptoms, making it impossible to 
observe the symptom onset time for all individuals. In this section, we assume an ideal 
situation where all serial intervals are observed, regardless of their length. In reality, this 
would mean a study of decades where ascertainment of transmission pairs is done 
without error in order to observe all the long serial intervals. Despite the impossibility of 
this scenario, for the purposes of better understanding the problem, we assume this ideal 
scenario and conduct a simulation study to compare the Maximum Likelihood Estimator 
(MLE) and an estimator derived under the Bayesian framework for the mean and median 
of the SI for TB. We further assume that both the symptom onset of the index case (time 
point A) and the symptom onset of the contacts (time point B) are observed with 
precision. 
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We propose a simulation framework for evaluating methods that can be used to estimate 
the serial interval in a household contact study. We propose multiple approaches to 
estimate the serial interval and within this framework, we evaluate the ability of each of 
these methods to estimate several plausible serial interval distributions. 
 
2.2 Methods 
 
2.2.1 Statistical methods 
 
We first introduce the likelihood functions that will be used in all estimation approaches 
described. As shown previously, SI distributions are likely left skewed (Figure 2.1b). 
Here we use the gamma and log-normal distributions. These are commonly used to 
parameterize the serial interval distribution due to their ability to handle skewness [11]. 
However, the approaches we show can be used for any parametric distribution. Let the 
observed serial intervals be denoted by xi, i = 1,2,…,n with an appropriate parametric 
distribution, 𝑓(𝑥𝑖). The joint likelihood function is: 
   1 2
1
                      ( | , ,..., ) ( | )                                             (2.1)
n
n i
i
L x x x f x 

  
where   is the parameter space in a parametric distribution and ( | )if x    is the 
probability density function (pdf) assumed for the serial interval. Here, we consider either 
the gamma (2) or log-normal (3) distribution. 
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*1                     ( | , ) ,   1,2,...,                                     (2.2)
( )
ix
i if x x e i n

 

 

2
2
2
(ln )1
                    ( | , ) exp( ),  1, 2,...,                    (2.3) 
22
i
i
i
x
f x i n
x

 
 

    
  
We propose two estimators of the SI distribution based on equation (1). We also show 
how the mean and median of these distributions can be obtained. 
 
Maximum likelihood estimator (MLE) 
 
To derive the MLE of the mean SI ˆ
MLE  , we first maximize equation (2.1) with respect 
to parameter  . For example, in the case of the gamma density (2.2), we estimate 𝜃 =
{?̂?𝑀𝐿𝐸 , ?̂?𝑀𝐿𝐸}. Then the MLE for the mean is 
ˆ
ˆ  .
ˆ
MLE
MLE
MLE



  Similarly, for the log-
normal density (3), the MLE of the mean SI is 
2ˆˆˆ exp( ) .         
2
MLE
MLE MLE

    
 
Given the MLE of the parameters in the parametric distribution, we can derive the 
median of the estimated serial interval distribution and evaluate the performance of the 
estimator for the median. When the parametric distribution is a gamma distribution, the 
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MLE for the median SI is derived by solving *
ˆ ˆ
ˆˆ 1
ˆ 1
( ) =     
ˆ( ) 2
MLE MLE
MLE MLE
m
xMLE
MLE
x e d x

 

 


numerically to obtain ˆ MLEm as the MLE for the median SI. When the parametric 
distribution is a log-normal distribution, the MLE for the median is 
ˆˆ exp( ) .         MLE MLEm   
 
We calculate a bootstrap 95% confidence interval (CI)  ˆ ˆ( , )L u   of the estimated mean 
ˆ
MLE  based on 10,000 bootstrap samples.  
 
Bayesian estimator 
 
We use the same parameterization for the SI as in equation (1), but specify a prior 
distribution for the mean of the SI. The posterior distribution of the parameter space   
is: 
 
1 2 1 2                   ( | , ,..., ) ( | , ,..., )* ( )                               (2.4)n np x x x L x x x     
where 
1 2( | , ,..., )nL x x x  is the joint likelihood function in equation (2.1) and ( )  is the 
prior distribution of the parameter space  . As we are interested in the mean or the 
median of the SI distributions, we first write the mean or the median SI as functions of 
the parameter space  . For example, for ( , )gamma    where   is the shape and   is 
the rate, the relationship of the mean and standard deviation (sd) of the gamma can be 
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written as 
2
2
mean
sd
   and 
2
mean
sd
  . Then, we can specify prior distributions for the 
mean SI through these relationships and derive the posterior distribution of the mean SI. 
The Bayesian estimator for the mean SI, denoted by  , is the mean of the posterior 
distribution, which is approximated sampling from the posterior distribution using 
Markov Chain Monte Carlo (MCMC) methods. A 95% credible interval ( , )L u   is 
derived by taking the 2.5th and 97.5th percentile of the posterior distribution of the mean 
SI. The Bayesian estimator for the median SI, denoted by m is derived by solving 
*1 1( )
( ) 2
m
xx e d x

 

 



numerically when a gamma distribution is used to parameterize 
the SI. A 95% credible interval ( , )L u    is derived by solving 
*1 ( ) 0.025
( )
L
xx e d x
 
 

 



and 
*1 ( ) 0.025 .
( )
U
xx e d x

 




  
  
When a log-normal distribution is used to parameterize the SI, the Bayesian estimator for 
the median SI is exp( )m  , where  is the Bayesian estimator of the location 
parameter in the log-normal distribution. Exponentiating the 2.5th and 97.5th percentile of 
the posterior distribution for the location parameter gives the 95% credible interval for 
m . 
 
We evaluate the impact of different prior distributions including an informative prior, a 
weakly informative prior, and a misspecified prior. In practice, an informative prior is 
appropriate when we have relevant data or existing, reliable estimates of the serial 
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interval distribution or mean. Such information could be obtained from other studies. A 
weakly informative prior is appropriate when there is very little existing information 
about the serial interval distribution. We risk using a misspecified (informative) prior 
distribution when using an informative prior that is not appropriate for the setting we are 
studying.  
 
2.3 Simulation Study 
 
We run 10,000 simulations for each of the scenarios described below. We simulate a total 
of 50, 200, or 500 households to correspond with a small, medium, or large household 
contact study, respectively. For each household, a random number household contacts is 
drawn from a Poisson distribution with mean six. The choice of this Poisson parameter is 
consistent with empirical data [19]. A binomial distribution with p=0.8 is used to estimate 
the proportion of contacts who are infected with TB. Among those who are infected, a 
binomial distribution with p=0.1 is used to estimate the proportion of those who develop 
active disease. Both binomial parameters are chosen based on consensus estimates of 
risks of TB infection and disease [2,4,5]. For those who develop active disease and 
therefore show symptoms, a serial interval, measured in days, is drawn from one of the 
known parametric distributions (Table 2.1). In the results section, non-heavy-tailed 
distributions are labeled with “N”, heavy-tailed distributions are labeled as “H”, and 
mixture distributions are labeled with “M”. 
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Table 2. 1: True underlying SI distributions (years) 
 
Type of 
distribution 
Distribution (label) Mean Standard 
deviation 
Non-heavy-
tailed  
Gamma (2, 0.004) 
(N1) 
1.37 0.97 
Gamma (2.5, 0.004) 
(N2) 
1.71 1.08 
Gamma (1.8, 0.003)  
(N3) 
1.64 1.22 
 
Heavy-tailed  Log-normal (6, 1) 
(H1) 
1.82 2.39 
Log-normal (6.3, 1) 
(H2) 
2.46 3.22 
Log-normal (6.5, 1) 
(H3) 
3.01 3.94 
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Mixture Gamma (2, 0.004) and 
gamma (50, 0.01) 
with probabilities 
(80%, 20%) (M1) 
3.84 5.08 
Gamma (2, 0.004) and 
gamma (50, 0.01) and 
(50, 0.01) with 
probabilities (95%, 
5%) (M2) 
1.99 2.88 
 
The non-heavy-tailed distributions correspond to scenarios where long SIs are relatively 
rare; the heavy-tail distributions depict scenarios where long SIs have higher probability 
than the non-heavy-tailed distributions; the mixture distributions are chosen to represent 
with scenarios where longer SIs create a second mode in the underlying distribution. 
These longer SIs can be attributed to reactivation TB disease, as described in the 
introduction. For example, for a mixture of gamma (2, 0.004) (mean of 1.4 years) and 
gamma (50, 0.01) (mean of 13.7 years) with probabilities (0.95, 0.05), 95% of the serial 
intervals come from gamma (2, 0.004) and 5% of the serial intervals come from gamma 
(50, 0.01). 
 
We chose the above distributions (Table 2.1) to be consistent with the limited empirical 
serial interval data [24] or to represent hypotheses about unobserved transmission 
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dynamics (e.g. bimodality in the serial interval distribution). For example, Figure 2.1a 
shows a simulated dataset from a log-normal (6, 1) with mean 1.82 years and standard 
deviation 2.39 years, whereas Figure 2.1b is from a serial interval distribution reported in 
Brooks-Pollock et al.[24]. To evaluate the simulations, we compare the estimated mean 
SI to the true mean SI. We also explore results when using the median as a representation 
of the SI distribution by comparing the estimated median SI to the true median SI to 
determine if the conclusions are consistent.  
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Figure 2.1a: A simulated serial interval distribution from log-normal (6, 1) with mean 
1.82 years and standard deviation 2.39 years. 
 
Figure 2.1b: Serial interval distribution reported in Brooks-Pollock et al. [24] 
Figure 2. 1: Serial interval distribution from real data 
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1. To evaluate the estimators described in the methods, we calculate three quantities 
for each simulation. The first is the Mean Squared Error (MSE), given by   
 
2ˆ( )
ˆ                    ( ) ,  1,2,...,10,000                           (2.5)
j
j j
j
MSE j
n
 


   
where μ is the true mean of the serial interval and nj is the sample size in the jth 
simulation run. This is calculated for each of the 10,000 simulation runs in each scenario, 
and is summarized as a distribution with median, 1st and 3rd quantile. 
 
2. The coverage probability (denoted by cov erp  of the 95% credible interval or 
confidence interval, denoted by ˆ ˆ( , )L u  ) is calculated as one value for each 
scenario. This counts how many times the 95% CIs (confidence interval or 
credible interval) cover the true value of the mean SI out of the 10,000 
simulations, and is defined as 
 
10,000
1
cov
ˆ ˆ ˆ( )
                                                                             (2.6)
10,000
Lj Ujj
j
er
I
p
  

 


 
where I  is the indicator function, ˆ
j  is the MLE or Bayesian estimator for the j
th 
simulation run. 
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3. The width of the 95% credible interval is calculated by subtracting the lower 
bound of the 95% interval from the upper bound of the 95% interval 
 ˆ ˆ                   , 1,2,...,10,000.                                                (2.7)j Lj UjCI j      
This is calculated for each of the 10,000 simulation runs in each scenario, and is 
summarized as a distribution with median, 1st and 3rd quantile. 
 
We focus on the comparison of MLE and Bayesian method with different prior 
distributions, which are listed in Table 1 in the appendix. As the mean serial interval is a 
positive quantity, gamma distributions are chosen as the informative and misspecified 
priors. For example, when the true mean SI is 500 days, a gamma (10, 0.02) with a mean 
of 500 days and a standard deviation of 158 days is chosen as an informative prior. This 
would mean that our prior knowledge regarding the mean SI is correct, even though we 
allow sufficient variation with a fairly large standard deviation of 158 days.  For the same 
true underlying SI, a misspecified prior is chosen as gamma (8, 0.002) with a mean of 
4000 days and a standard deviation of 1414 days. This would mean that the prior 
knowledge on the mean SI is misspecified as it is much larger than the true mean SI. A 
weakly informative prior is chosen as a half-normal with a mean 0 and a very large 
standard deviation with the purpose of creating a flat prior for the mean SI as a positive 
quantity. 
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To compare models with the gamma and log-normal parameterization, we will use the 
Akaike information criterion (AIC), which is 2 2log ( | )k p x  , where k is the number 
of parameters estimated and p is the likelihood function based on the data and the 
estimated parameters  . For the Bayesian approach, we additionally consider the 
deviance information criterion (DIC) [84], which is computed as, 
1
1
2*(log ( | ) log ( | ))                                                    (2.8)
S
s
Bayes
s
DIC p x p x
S
 

    
where ( | )Bayesp x  is the likelihood function based on the Bayesian estimator, which is 
the mean of the posterior distribution of parameter space  ; S is the total number of 
posterior samples retained from the MCMC sampling and ( | )sp x  is the likelihood 
function evaluated at each of the MCMC samples. The lower the AIC or DIC is, the 
better the parameterization is. 
 
All simulations and analyses are conducted in R 3.4.0 [85] and OpenBUGS 3.2.3 [86]. 
 
2.4 Household Contact Data 
 
We propose to analyze three sources of data, described below. We will use the MLE 
approach with both the gamma and log-normal parameterization to estimate the serial 
interval. We will also use the Bayesian approach where we will evaluate the impact of 
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different prior distributions. For an informative prior, we consider two sources of 
information from [20,23], where the median serial intervals were estimated to be around 
1.4 years. As the SI distribution is likely left-skewed, we will use a gamma distribution 
with a mean of 2 years for an informative prior on the mean SI. 
 
The first dataset is from a 4-year household contact study in Peru with 408 household 
contacts who developed TB disease after exposure to their 263 index cases described in 
Brooks-Pollocks et al. [24]. In this study, subjects were linked by household structure and 
time between diagnosis of index cases and their corresponding secondary cases was used 
as a surrogate for the serial interval. As this study began in 1996, we excluded the SIs 
where the corresponding index cases were diagnosed before 1996, leaving 254 observed 
serial intervals. 
 
The second dataset is described in Ferebee [87], which reported TB cases among contacts 
of infectious TB cases in a clinical trial at United States Public Health Service (USPHS) 
for subjects that had been exposed to TB and then assigned to either isoniazid (to prevent 
the development of active TB disease) or placebo. We propose to analyze the serial 
intervals for the placebo group in this trial. These contacts were followed up for up to 10 
years, with individual follow-up stopping in the 6th year. After the 6th year, contacts 
were followed up by checking against a roster of newly reported cases in the health 
departments. The percentage of loss-to-follow-up subjects was 1.2% in 1967 for the 
contacts of new TB cases. This study contained information that could be used for 
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estimating the serial interval. For example, there were 86 cases within the first year and 
18 cases within the second year. The midpoint in each year was assigned to each subject 
as the precise symptom onset day was not specified. For example, the 18 cases within the 
second year were assigned serial intervals of 1.5 years. 
 
For the third dataset, we consider 40 household contacts who developed disease after 
exposure to their 36 index cases in a household contact study in Brazil [88]. This data is 
analyzed in a similar fashion as the data from the Peruvian household contact study, 
using diagnosis date as a surrogate for disease onset and assuming that the time from 
onset to diagnosis is independent and identically distributed for index and secondary 
cases. The household contacts that were diagnosed within 3 months of their index cases 
were excluded from the analysis, as they are considered as co-prevalent cases (i.e. cases 
that were identified so close in time to the index case that transmission from the index 
case seems implausible). 
 
2.5 Results 
 
2.5.1 Simulation results 
 
As expected, correctly specifying the SI distribution is important for MLE estimation and 
Bayesian estimation with a weakly informative prior. We observe that the estimator from 
  75 
a parametric distribution that matches the underlying distribution performed consistently 
better than a mismatch of distributions, leading to estimates with a lower MSE. When 
using an informative prior, the Bayesian estimator performed consistently better than the 
MLE approach (Tables 2.3-2.10). When the prior distribution was inconsistent with the 
underlying SI distributions such that the mean SI in the priors was much larger than the 
true mean SI, the estimator performed poorly for the smaller sample sizes, particularly 
when the parameterization was a mismatch with the underlying distribution.  
 
When the true underlying distribution was a mixture, the performance of the estimators 
varied depending on the mixture probabilities. For instance, if 20% of the serial intervals 
were in the second mode of the distribution, then the gamma parameterization uniformly 
performed better for both the MLE and Bayesian approaches. When this probability 
decreased to 5%, the log-normal parameterization was optimal. When using an 
informative prior, the Bayesian estimator provided a lower MSE than the MLE. (Table 
2.3) 
 
AIC results showed that in the vast majority of the cases, the parameterization that 
matches the underlying distribution provided a better fit with lower AIC; DIC results for 
the Bayesian method yielded the same conclusion (Table 2.15). The gamma 
parameterization produced lower AIC when the underlying distribution has more density 
in the second mode (80%, 20% mixture), while the log-normal distribution produced 
lower AIC when the underlying distribution is a 95%, 5% mixture. 
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2.5.2 Household Contact Studies 
 
2.5.2.1 Lima, Peru 
 
In this 4-year household contact study in Peru, a total of 408 household contacts 
developed TB disease after exposure to their 263 index cases. After excluding the SIs 
with index cases diagnosis dates prior to 1996, the start of the study, a total of 254 SIs 
were analyzed. The MLE estimate of the mean SI was 2.8 years (95% confidence 
interval: 2.57-3.09 years) with a gamma parameterization and 3.7 years (95% confidence 
interval: 3.13-4.13 years) for the log-normal parameterization. Bayesian estimates with a 
weakly informative prior were similar to the MLE (gamma: 2.8 years, 95% CI: 2.53-3.17 
years; log-normal: 3.5 years, 95% CI: 2.99-4.11 years). Using an informative prior (a 
gamma distribution with a mean of around 2 years) did not alter the gamma results (2.7 
years, 95% CI: 2.44-2.98 years), but brought the results from the log-normal 
parameterization to be more consistent with the gamma parameterization (2.7 years, 95% 
CI: 2.40-3.02 years). The gamma parameterization yielded lower AIC and DIC compared 
to the log-normal parameterization regardless of the estimation approach, indicating that 
the gamma distribution provided a better fit for the data (Tables 2.12 and 2.13). 
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2.5.2.2 US Public Health Service, 1956-1966 
 
During 10 years of follow-up, there were 211 observed serial intervals in the placebo 
group. The MLE for the mean of the serial interval was lower in the parameterization 
compared to the log-normal parameterization (gamma: 2.6 years, 95% CI: 2.31-2.93 
years; log-normal: 2.8 years, 95% CI: 2.38-3.21 years). A similar pattern was observed in 
the weakly informative Bayesian estimates (gamma: 2.6 years, 95% CI: 2.34-3.01 years; 
2.8 years, 95% CI: 2.36-3.26 years). Bayesian estimation with an informative prior (a 
gamma distribution with a mean of around 2 years) only modified the estimates slightly 
for the gamma parameterization: 2.5 years, 95% CI: 2.21-2.75 years; however, the 
informative prior resulted in a lower estimate for the log-normal parameterization:  2.3 
years, 95% CI: 2.05-2.61 years). The log-normal parameterization yielded lower AIC and 
DIC compared to the gamma parameterization regardless of the estimation approach, 
indicating that the log-normal distribution provided a better fit for the data. This was 
expected as an increased number of longer SIs were observed in this study, favoring the 
log-normal distribution, which has a heavier tail (Tables 2.12 and 2.13). 
 
2.5.2.3 Vitoria, Brazil, 2008-2013 
 
A total of 25 SIs were included in the analysis after excluding the co-prevalent cases 
(defined as the household contacts that were diagnosed within 3 months of their index 
cases). The estimated serial intervals were slightly lower than those for Peru and USPHS 
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and did not vary substantially depending on the parameterization used. For instance, the 
MLE with the gamma was 2.4 years (95% CI: 1.72-3.02 years) while the log-normal was 
2.6 years (95% CI: 1.82-3.34 years). As expected, the Bayesian estimates with a weakly 
informative prior were similar to the MLE estimates. Using an informative prior (a 
gamma distribution with a mean of 2 years) yielded lower estimates regardless of the 
parameterization, which was expected due to the smaller sample size (Table A10). The 
gamma parameterization yielded lower AIC and DIC compared to the log-normal 
parameterization regardless of the estimation approach, indicating that the gamma 
distribution provided a better fit for the data (Tables 2.12 and 2.13). 
For all 3 real datasets we analyzed, the pattern for the median SI was similar to the mean 
SI (Table 2.11). 
 
2.6 Discussion 
 
In this chapter, we have described two estimation frameworks, frequentist and Bayesian 
for estimating the serial interval of TB and evaluated them through simulation. Under 
various different plausible underlying distributional assumptions for the serial interval, 
we examined the impact of misspecification of the parametric form of the serial interval, 
the sample size, and three types of prior distributions (informative, weakly informative, 
misspecified). We also illustrated these methods using data from three studies of TB 
transmission. 
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From the simulation results, we found that it is important to correctly specify the 
parametric distribution. In reality, this can be done by comparing model fit using AIC and 
DIC statistics. When there is credible prior information on the SI distribution, the 
Bayesian approach is preferred over the MLE approach. However, given that one would 
likely never know if this prior information is credible, it is possible that this can create 
biased results, as we show when the prior is incorrectly specified. We also found in our 
simulations that the gamma parameterization is preferred when there is a strong bimodal 
distribution. As the log-normal distribution has a heavier tail than the gamma distribution, 
this is counterintuitive and warrants further investigation. 
 
In general, using real data from TB studies, we found that the log-normal distribution 
yielded slightly longer mean SI estimates than the gamma distribution. This is expected 
as the log-normal distribution has a heavier tail than the gamma distribution. For the 
informative priors, we considered two sources of information, Leung et al. [20] and 
Borgdorff et al. [23]. These priors resulted in lower SI estimates. As there are limited 
existing SI estimates, it may be challenging to find credible information to use as prior 
distributions for the Bayesian estimator. 
 
To conclude, we found that credible source of information on the SI should be used in a 
Bayesian approach. A log-normal distribution should be used when longer SIs are 
observed, although it may not necessarily perform better than the gamma distribution as 
the underlying SI distribution may be bimodal with heavy density in the second mode. 
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Table 2. 2: True underlying SI distributions (days) and prior distributions ( )  
for the mean and standard deviation of the SI 
 
Types 
  
Distribu 
-tion 
(label), 
mean, 
standar
d 
deviatio
n (SD) 
Prior distributions 
Informative Weakly 
informative 
Misspecified 
Mean SD Mean SD Mean SD 
Non-
heavy-
tailed 
G (2, 
0.004) 
(N1)  
Mean: 
500, SD: 
354 
G (10, 
0.02) 
with 
mean 
500 
and 
SD 
158 
G (11, 
0.03) 
with 
mean 
367 
and 
SD 
111 
HN (0, 
0.00000
1)  
HN (0, 
0.00000
1) 
G (8, 
0.002) 
with 
mean 
4000 
and 
SD 
1414 
G (8, 
0.002
) with 
mean 
4000 
and 
SD 
1414 
G (2.5, 
0.004) 
(N2) 
G (13, 
0.02) 
with 
G (12, 
0.03) 
with 
HN(0, 
0.00000
1) 
HN (0, 
0.00000
1) 
G (8, 
0.002) 
with 
G (8, 
0.002
) with 
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Mean: 
625, SD: 
395 
mean 
650 
and 
SD 
180 
mean 
400 
and 
SD 
115 
mean 
4000 
and 
SD 
1414 
mean 
4000 
and 
SD 
1414 
G (1.8, 
0.003)  
(N3) 
Mean: 
600, SD: 
447 
G (13, 
0.02) 
for 
with 
mean 
650 
and 
SD 
180 
G (12, 
0.03) 
with 
mean 
400 
and 
SD 
115 
HN (0, 
0.00000
1) 
HN (0, 
0.00000
1) 
G (8, 
0.002) 
with 
mean 
4000 
and 
SD 
1414 
G (8, 
0.002
) with 
mean 
4000 
and 
SD 
1414 
 
Heavy
-tailed 
LN (6, 
1) (H1) 
Mean: 
665, SD: 
872 
G (13, 
0.02) 
with 
mean 
665 
and 
SD 
180 
G (17, 
0.02) 
with 
mean 
850 
and 
SD 
206 
HN (0, 
0.00000
1) 
HN (0, 
0.00000
1) 
G (8, 
0.002) 
with 
mean 
4000 
and 
SD 
1414 
G (8, 
0.002
) with 
mean 
4000 
and 
SD 
1414 
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LN (6.3, 
1) (H2) 
Mean: 
898, SD: 
1176 
G (18, 
0.02) 
with 
mean 
900 
and 
SD 
212 
G (35, 
0.03) 
with 
mean 
1167 
and 
SD 
197 
HN (0, 
0.00000
1) 
HN (0, 
0.00000
1) 
G (8, 
0.002) 
with 
mean 
4000 
and 
SD 
1414 
G (8, 
0.002
) with 
mean 
4000 
and 
SD 
1414 
LN (6.5, 
1) (H3) 
Mean: 
1097, 
SD: 
1438 
G (22, 
0.02) 
with 
mean 
1100 
and 
SD 
235 
G (43, 
0.03) 
with 
mean 
1433 
and 
SD 
219 
HN (0, 
0.00000
1) 
HN (0, 
0.00000
1) 
G (8, 
0.002) 
with 
mean 
4000 
and 
SD 
1414 
G (8, 
0.002
) with 
mean 
4000 
and 
SD 
1414 
 
Mix 
-ture 
G (2, 
0.004) 
and G 
(50, 
0.01) 
with 
G (14, 
0.01) 
with 
mean 
1400 
and 
G (20, 
0.01) 
with 
mean 
2000 
and 
HN (0, 
0.00000
1) 
HN (0, 
0.00000
1) 
G (8, 
0.002) 
with 
mean 
4000 
and 
G (8, 
0.002
) with 
mean 
4000 
and 
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probabi-
lities 
(80%, 
20%) 
(M1) 
Mean: 
1400, 
SD: 
1855 
SD 
374 
SD 
447 
SD 
1414 
SD 
1414 
G (2, 
0.004) 
and G 
(50, 
0.01) 
and (50, 
0.01) 
with 
probabi-
lities 
(95%, 
5%) 
(M2) 
G (7, 
0.01) 
with 
mean 
700 
and 
SD 
265 
G (11, 
0.01) 
with 
mean 
1100 
and 
SD 
332 
HN (0, 
0.00000
1) 
HN (0, 
0.00000
1) 
G (8, 
0.002) 
with 
mean 
4000 
and 
SD 
1414 
G (8, 
0.002
) with 
mean 
4000 
and 
SD 
1414 
  84 
Mean: 
725, SD: 
1051 
  Footnote: G: gamma; HN: half-normal; LN: log-normal. 
 
Table 2. 3: Complete results where all serial intervals are observed regardless of their 
length. Underlying SI is from a gamma (2, 0.004) denoted by N1. Inf=Informative, 
Weak=weakly informative, mis=misspecified, LN=Log-normal 
 
Table 2. 3a: Mean Squared Error (MSE) 
MSE: 
median 
( 
25th -
75th 
percen-
tile) 
 
A B C D E F G H 
50 92 
(20-
275) 
114 
(25-
357) 
48 
(11-
148) 
104 
(23-
332) 
12880 
(4558-
33060) 
76 
(18-
188) 
302 
(70-
838) 
37060 
(27390-
49980) 
  85 
200 5.5 
(1-
16) 
10 (2-
30) 
4 (1-
14) 
 
6 (1-
17) 
19 (5-
51) 
4 (0.9-
13.3) 
 
19 (5-
51) 
263 (137-
467) 
500 0.9 
(0.2-
2.6) 
3 
(0.7-
7.3) 
0.8 
(0.2-
2.4) 
0.9 
(0.2-
2.7) 
1.5 
(0.3-
4.2) 
2 (0.4-
4.5) 
 
4 (1-
10) 
17 (9-22) 
 
 
Table 2. 3b: Coverage probability 
Coverage 
probability 
 
A B C D E F G H 
50 0.913 0.935 0.973 0.947 0.172 0.997 0.941 0.0001 
200 0.942 0.934 0.961 0.951 0.821 0.982 0.920 0.288 
500 0.944 0.860 0.953 0.948 0.908 0.948 0.864 0.490 
 
Table 2. 3c: Width of 95% confidence interval or credible interval 
Width: 
median 
(25th -75th 
percentile) 
A B C D E F G H 
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50 258 
(222-
303) 
287 
(242-
342) 
 
238 
(220-
257) 
 
312 
(267-
367) 
1450 
(994-
1879) 
316 
(299-
342) 
 
465 
(393-
534) 
1307 
(1239-
1382) 
200 136 
(125-
148) 
152 
(139-
167) 
 
133 
(125-
141) 
 
142 
(131-
153) 
165 
(151-
181) 
153 
(145-
161) 
 
203 
(182-
228) 
342 
(286-
415) 
500 87 
(83-
92) 
 
97 
(92-
104) 
 
86 
(82-
90) 
 
88 
(84-
93) 
93 
(88-
98) 
108 
(103-
113) 
 
123 
(115-
132) 
144 
(132-
156) 
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Table 2. 4: Complete results where all serial intervals are observed regardless of their 
length. Underlying SI is from a gamma (2.5, 0.004) denoted by N2. Inf=Informative, 
Weak=weakly informative, mis=misspecified, LN=Log-normal 
 
Table 2.4a: Mean Squared Error (MSE) 
MSE: 
median, 
25th -75th 
percentile 
 
A B C D E F G H 
50 111 
(25-
337) 
127 
(27-
386) 
60 
(14-
181) 
121 
(27-
376) 
7391 
(2704-
19340) 
61 
(14-
180) 
244 
(53-
721) 
35410 
(24490-
49400) 
200 7 
(1.5-
21) 
10 
(2-
28) 
6 (1-
17) 
7 (2-
21) 
19 (5-
52) 
6 (1-
17) 
14 (3-
41) 
153 (73-
285) 
500 1.1 
(0.2-
3.3) 
2 
(0.5-
6) 
1.1 
(0.2-
3.1) 
1 (0.2-
3) 
2 (0.4-
4.8) 
1 
(0.3-
4) 
3 (0.7-
8) 
11 (5-
21) 
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Table 2.4b: Coverage probability 
Cov 
prob 
 
A B C D E F G H 
50 0.922 0.928 0.972 0.947 0.311 0.975 0.948 0.005 
200 0.939 0.939 0.957 0.950 0.858 0.978 0.945 0.522 
500 0.945 0.904 0.954 0.9502 0.921 0.961 0.918 0.689 
  Footnote: cov prob=coverage probability. 
Table 2.4c: Width or 95% confidence interval or credible interval 
Width: 
median, 
25th -75th 
percentile 
 
A B C D E F G H 
50 290 
(252-
339) 
310 
(266-
366) 
268 
(248-
290) 
340 
(293-
396) 
1163 
(796-
1608) 
264 
(248-
280) 
467 
(393-
542) 
1414 
(1337-
1496) 
200 152 
(141-
165) 
163 
(150-
177) 
149 
(140-
150) 
158 
(147-
170) 
179 
(165-
195) 
167 
(158-
177) 
207 
(188-
229) 
298 
(258-
348) 
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500 97 
(92-
102) 
104 
(99-
110) 
96 (92-
101) 
98 
(94-
103) 
103 
(98-
108) 
115 
(110-
121) 
127 
(119-
135) 
142 
(132-
153) 
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Table 2. 5: Complete results where all serial intervals are observed regardless of their 
length. Underlying SI is from a gamma (1.8, 0.003) denoted by N3. Inf=Informative, 
Weak=weakly informative, mis=misspecified, LN=Log-normal 
 
Table 2.5a: Mean Squared Error (MSE) 
MSE: 
median, 
25th -75th 
percentile 
 
A B C D E F G H 
50 151 
(32-
444) 
191 
(43-
615) 
67 
(14-
199) 
161 
(35-
505) 
14650 
(6045-
33020) 
78 
(18-
228) 
377 
(91-
1026) 
37270 
(27510-
50090) 
200 9 (2-
27) 
20 
(4-
58) 
7 
(1.5-
21) 
9 (2-
27) 
34 (8-
84) 
6 (1-
19) 
36 (9-
91) 
504 
(270-
859) 
500 1.5 
(0.3-
4.3) 
6 
(1.6-
15) 
1 
(0.3-
4) 
1.5 
(0.3-
4.4) 
2 (0.5-
7) 
2 (0.6-
7) 
9 (3-
20) 
36 (19-
60) 
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Table 2.5b: Coverage probability 
Coverage 
probability 
 
A B C D E F G H 
50 0.913 0.934 0.981 0.950 0.177 0.973 0.9496 0.0003 
200 0.941 0.925 0.964 0.951 0.815 0.985 0.910 0.233 
500 0.947 0.818 0.958 0.952 0.903 0.951 0.823 0.396 
 
Table 2.5c: Width of 95% confidence interval or credible interval 
Width: 
median, 
25th -75th 
percentile 
 
A B C D E F G H 
50 326 
(278-
383) 
371 
(309-
448) 
287 
(267-
308) 
 
389 
(334-
454) 
1454 
(1078-
1831) 
272 
(257-
288) 
543 
(476-
605) 
1356 
(1286-
1438) 
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200 172 
(158-
187) 
198 
(180-
219) 
166 
(156-
176) 
179 
(166-
194) 
211 
(192-
231) 
186 
(177-
195) 
265 
(237-
296) 
455 
(383-
538) 
500 110 
(104-
116) 
127 
(119-
136) 
108 
(103-
113) 
111 
(106-
117) 
118 
(112-
124) 
136 
(129-
142) 
162 
(151-
175) 
192 
(176-
210) 
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Table 2. 6: Complete results where all serial intervals are observed regardless of their 
length. Underlying SI is from a log-normal (6, 1), denoted by H1. Inf=Informative, 
Weak=weakly informative, mis=misspecified, LN=Log-normal 
 
Table 2.6a: Mean Squared Error (MSE)  
MSE: 
median, 
25th -75th 
percentile 
 
A B C D E F G H 
50 491 
(111-
1405) 
466 
(107-
1339) 
129 
(27-
393) 
444 
(100-
1371) 
28000 
(12920-
52770) 
74 
(17-
212) 
297 (64-
908) 
31980 
(23410-
44130) 
200 33 (7-
97) 
30 
(7-
90) 
22 
(5-
67) 
 
33 (7-
98) 
95 (21-
288) 
11 (2-
32) 
30 (6-
89) 
784 
(376-
1382) 
500 5.5 
(1-16) 
5 (1-
14) 
 
5 (1-
14) 
 
5 (1-
16) 
8 (2-
24) 
3 (0.6-
8.2) 
5 (1-14) 27 (8-
66) 
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Table 2.6b: Coverage probability 
Coverage 
probability 
 
A B C D E F H 
50 0.838 0.862 0.982 0.880 0.177 0.993 0.0006 
200 0.899 0.916 0.895 0.847 0.694 0.983 0.376 
500 0.925 0.939 0.862 0.841 0.783 0.970 0.736 
 
Table 2.6c: Width of 95% confidence interval or credible interval 
Width: 
median, 
25th -75th 
percentile 
 
A B C D E F G H 
50 499 
(378-
679) 
558 
(126-
758) 
386 
(360-
414) 
506 
(411-
625) 
1733 
(1451-
1987) 
342 
(324-
362) 
591 
(528-
648) 
1315 
(1240-
1401) 
200 300 
(252-
362) 
311 
(269-
361) 
231 
(213-
252) 
247 
(218-
280) 
260 
(189-
339) 
239 
(228-
250) 
329 
(294-
365) 
618 
(544-
690) 
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500 199 
(176-
231) 
199 
(181-
219) 
151 
(141-
162) 
154 
(142-
168) 
167 
(153-
182) 
175 
(167-
184) 
205 
(189-
222) 
259 
(236-
286) 
 
  
  96 
Table 2. 7: Complete results where all serial intervals are observed regardless of their 
length. Underlying SI is from a log-normal (6.3, 1), denoted by H2. Inf=Informative, 
Weak=weakly informative, mis=misspecified, LN=Log-normal 
 
Table 2.7a: Mean Square Error (MSE) 
MSE: 
median, 
25th -75th 
percentile 
 
A B C D E F G H 
50 897 
(204-
2559) 
848 
(194-
2438) 
344 
(92-
859) 
696 
(155-
2069) 
24190 
(10940-
46710) 
106 
(24-
310) 
397 
(86-
1143) 
29650 
(20910-
42240) 
200 59 
(13-
176) 
56 
(12-
164) 
43 
(10-
125) 
57 
(13-
171) 
149 
(33-
453) 
14 (3-
41) 
45 
(10-
129) 
881 
(396-
1597) 
500 10 (2-
29) 
9 (2-
26) 
8 (2-
25) 
10 (2-
29) 
13 (3-
41) 
4 (0.8-
11) 
8 (2-
23) 
39 (10-
97) 
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Table 2.7b: Coverage probability 
Coverage 
probability 
 
A B C D E F G H 
50 0.838 0.861 0.975 0.889 0.299 0.992 0.971 0.025 
200 0.899 0.916 0.890 0.849 0.721 0.990 0.961 0.504 
500 0.924 0.9389 0.857 0.842 0.792 0.980 0.952 0.779 
 
Table 2.7c: Width of 95% confidence interval or credible interval 
Width: 
median, 
25th -75th 
percentile 
 
A B C D E F G H 
50 673 
(509-
917) 
752 
(572-
1023) 
482 
(458-
510) 
 
633 
(526-
755) 
 
 
 
1703 
(1443-
1948) 
410 
(388-
435) 
676 
(612-
736) 
1431 
(1352-
1518) 
  98 
200 405 
(340-
488) 
421 
(363-
487) 
 
307 
(288-
326) 
328 
(291-
370) 
406 
(355-
466) 
286 
(276-
297) 
411 
(373-
449) 
711 
(637-
783) 
500 269 
(237-
311) 
269 
(245-
296) 
203 
(191-
217) 
207 
(191-
225) 
224 
(205-
244) 
218 
(210-
225) 
268 
(248-
289) 
336 
(307-
368) 
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Table 2. 8: Complete results where all serial intervals are observed regardless of their 
length. Underlying SI is from a log-normal (6.5, 1), denoted by H3. Inf=Informative, 
Weak=weakly informative, mis=misspecified, LN=Log-normal 
 
Table 2.8a: Mean Square Error (MSE) 
MSE: 
median, 
25th -75th 
percentile 
 
A B C D E F G H 
50 1340 
(304-
3818) 
1264 
(290-
3638) 
588 
(198-
1279) 
927 
(207-
2678) 
21680 
(9474-
42720) 
141 
(32-
418) 
589 
(139-
1717) 
26770 
(18090-
39370) 
200 88 
(19-
263) 
83 
(18-
245) 
70 
(16-
195) 
81 
(18-
242) 
195 
(43-
593) 
18 
(4-
53) 
58 
(13-
171) 
501 
(245-
798) 
500 15 (3-
43) 
13 
(3-
38) 
13 (3-
38) 
14 (3-
42) 
19 (4-
58) 
5 (1-
15) 
11 (3-
33) 
47 (12-
122) 
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Table 2.8b: Coverage probability 
Coverage 
probability 
 
A B C D E F G 
50 0.837 0.861 0.891 0.403 0.992 0.958 0.132 
200 0.898 0.916 0.850 0.742 0.991 0.959 0.746 
500 0.924 0.9390 0.845 0.801 0.983 0.953 0.810 
 
Table 2.8c: Width of 95% confidence interval or credible interval 
Width: 
median, 
25th -75th 
percentile 
 
A B C D E F G H 
50 821 
(623-
1119) 
919 
(700-
1249) 
562 
(536-
592) 
 
725 
(611-
849) 
1710 
(1473-
1945) 
478 
(453-
507) 
736 
(673-
799) 
1511 
(1428-
1604) 
200 495 
(416-
596) 
513 
(444-
595) 
368 
(348-
389) 
392 
(350-
441) 
484 
(425-
554) 
335 
(324-
347) 
472 
(433-
509) 
505 
(433-
594) 
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500 328 
(290-
381) 
328 
(299-
361) 
247 
(233-
263) 
251 
(232-
273) 
271 
(249-
295) 
257 
(249-
266) 
317 
(296-
340) 
398 
(365-
434) 
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Table 2. 9: Complete results where all serial intervals are observed regardless of their 
length. Underlying SI is from a mixture of gammas: (2, 0.004) and (50, 0.01) with 
probabilities (80%, 20%), denoted by M1. Inf=Informative, Weak=weakly informative, 
mis=misspecified, LN=Log-normal 
 
Table 2.9a: Mean Squared Error (MSE) 
MSE: 
media
n, 
25th -
75th 
percen
-tile 
 
A B C D E F G H 
50 2645 
(555-
7870) 
4332 
(928-
12560
) 
543 
(128-
1589) 
1294 
(279-
4032) 
30400 
(15940-
50720) 
991 
(273-
2227) 
4444 
(1706-
8770) 
30090 
(19840
-
44650) 
200 158 
(35-
449) 
269 
(58-
791) 
97 
(22-
280) 
122 
(27-
363) 
497 
(126-
1251) 
154 
(41-
362) 
338 
(100-
761) 
918 
(312-
1861) 
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500 25 (6-
72) 
43 
(10-
129) 
20 
(4.5-
60) 
22 (5-
65) 
42 (9-
118) 
31 (7-
81) 
47 
(12-
124) 
96 
(23-
255) 
 
Table 2.9b: Coverage probability 
Cov 
prob 
 
A B C D E F G H 
50 0.887 0.836 0.992 0.894 0.427 0.944 0.676 0.114 
200 0.935 0.914 0.952 0.910 0.776 0.905 0.786 0.803 
500 0.949 0.936 0.928 0.915 0.854 0.909 0.859 0.857 
        Footnote: cov prob=coverage probability. 
Table 2.9c: Width of 95% confidence interval or credible interval 
Width: 
median, 
25th -75th 
percentile 
 
A B C D E F G H 
50 1409 
(1222-
1602) 
1871 
(1433-
2370) 
858 
(817-
804) 
951 
(850-
1042) 
1989 
(1832-
2149) 
685 
(647-
729) 
780 
(720-
845) 
1507 
(1415-
1614) 
  104 
200 721 
(674-
768) 
957 
(838-
1089) 
564 
(532-
595) 
577 
(529-
623) 
768 
(696-
841) 
501 
(481-
523) 
565 
(532-
596) 
976 
(917-
1033) 
500 458 
(440-
477) 
610 
(560-
663) 
382 
(363-
402) 
384 
(361-
407) 
431 
(403-
461) 
398 
(382-
414) 
437 
(414-
459) 
634 
(587-
681) 
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Table 2. 10: Complete results where all serial intervals are observed regardless of their 
length. Underlying SI is from a mixture of gammas: (2, 0.004) and (50, 0.01) with 
probabilities (95%, 5%), denoted by M2. Inf=Informative, Weak=weakly informative, 
mis=misspecified, LN=Log-normal 
 
Table 2.10a: Mean Squared Error (MSE) 
MSE: 
median, 
25th -75th 
percentile 
 
A B C D E F G H 
50 884 
(190-
2465) 
723 
(168-
1922) 
463 
(111-
1102) 
898 
(184-
2317) 
27820 
(11030-
53920) 
120 
(27-
352) 
377 
(86-
1063) 
29790 
(21490-
33700) 
200 51 
(12-
146) 
51 
(12-
136) 
43 
(10-
127) 
51 
(11-
148) 
133 
(29-
395) 
21 
(5-
62) 
39 (9-
111) 
493 
(155-
1062) 
500 8 (2-
24) 
10 
(2-
26) 
8 
(1.8-
23) 
8 
(1.9-
24) 
12 (3-
36) 
6 (1-
16) 
8 (1.8-
22) 
12 (3-
37) 
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Table 2.10b: Coverage probability 
Cov 
prob 
 
A B C D E F G H 
50 0.749 0.760 0.937 0.777 0.267 0.993 0.950 0.011 
200 0.902 0.831 0.831 0.801 0.650 0.961 0.914 0.588 
500 0.925 0.822 0.805 0.792 0.733 0.915 0.876 0.869 
       Footnote: cov prob=coverage probability. 
Table 2.10c: Width of 95% confidence interval or credible interval 
Width: 
median, 
25th -75th 
percentile 
 
A B C D E F G H 
50 731 
(350-
964) 
672 
(394-
957) 
495 
(433-
551) 
 
560 
(396-
702) 
1740 
(1448-
1987) 
449 
(422-
478) 
591 
(512-
662) 
1345 
(1273-
1425) 
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200 403 
(347-
458) 
353 
(295-
417) 
270 
(239-
301) 
274 
(236-
315) 
345 
(292-
403) 
291 
(269-
311) 
325 
(282-
368) 
595 
(502-
679) 
500 258 
(235-
281) 
225 
(201-
250) 
171 
(156-
186) 
171 
(155-
188) 
186 
(168-
205) 
195 
(180-
209) 
202 
(183-
223) 
251 
(223-
281) 
 
Footnotes for tables 2.3-2.10: A: MLE Gamma; B: MLE log-normal; C: Bayesian gamma 
informative; D: Bayesian gamma weak; E: Bayesian gamma misspecified; F: Bayesian 
log-normal informative; G: Bayesian log-normal weak; H: Bayesian log-normal 
misspecified. 
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Table 2. 11: Complete data project real data analysis results 
 
- Mean SI in years, estimates and 95% CIs 
Study MLE 
gamma 
MLE 
LN 
Bayesian 
weak 
gamma 
Bayesian 
informative 
gamma 
Bayesian 
weak LN 
Bayesian 
informa 
-tive 
LN 
Lima, 
Peru, 
N=254 
2.8 
(2.57-
3.09) 
3.7 
(3.13-
4.13) 
2.8 (2.53-
3.17) 
2.7 (2.44-
2.98) 
3.5 (2.99-
4.11) 
2.7 (2.40-
3.02) 
USPHS 
N=211 
2.6 
(2.31-
2.93) 
2.8 
(2.38-
3.21) 
2.6 (2.34-
3.01) 
2.5 (2.21-
2.75) 
2.8 (2.36-
3.26) 
2.3 (2.05-
2.61) 
Brazil 
N=25 
2.4 
(1.72-
3.02) 
2.6 
(1.82-
3.34) 
2.5 (1.79-
3.42) 
2.1 (1.69-
2.59) 
2.6 (1.82-
3.72) 
2.0 (1.53-
2.43) 
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- Median SI in years, estimates and 95% CIs 
Study MLE 
gamma 
MLE 
LN 
Bayesian 
weak 
gamma 
Bayesian 
informative 
gamma 
Bayesian 
weak 
LN 
Bayesian 
informative 
LN 
Lima, 
Peru, 
N=254 
2.1 
(1.87-
2.39) 
1.8 
(1.56-
2.08) 
2.1 (2.10-
2.15) 
2.1 (2.00-
2.08) 
1.8 
(1.56-
2.05) 
1.8 (1.42-
1.78) 
USPHS 
N=211 
1.9 
(1.66-
2.17) 
1.6 
(1.37-
1.83) 
1.9 (1.90-
1.96) 
1.8 (1.76-
1.87) 
1.6 
(1.38-
1.85) 
1.5 (1.30-
1.65) 
Brazil 
N=25 
1.9 
(1.24-
2.48) 
1.7 
(1.05-
2.24) 
2.0 (1.79-
2.01) 
1.8 (1.47-
1.92) 
1.7 
(1.16-
2.30) 
1.5 (1.12-
1.88) 
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Table 2. 12: AIC statistics for real data analysis 
 
Study MLE 
gamma 
MLE  
LN 
Bayesia
n weak 
gamma 
Bayesian 
informa 
-tive 
gamma 
Bayesian 
weak LN 
Bayesian 
informa 
-tive 
LN 
Lima, 
Peru, 
N=254 
4028.1 4125.2 4028.1 4029.2 4113.3 4127.5 
USPHS 
N=211 
3320.5 3315.9 3320.6 3321.8 3315.0 3321.1 
Brazil 
N=25 
389.0 392.2 389.2 390.0 391.7 394.4 
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Table 2. 13: DIC statistics for real data analysis 
 
Study MLE 
gamma 
MLE 
LN 
Bayesian 
weak 
gamma 
Bayesian 
informative 
gamma 
Bayesian 
weak 
LN 
Bayesian 
informative 
LN 
Lima, 
Peru, 
N=254 
NA NA 4028.2 4028.8 4112.9 4126.9 
USPHS 
N=211 
NA NA 3320.4 3321.4 3314.6 3320.6 
Brazil 
N=25 
NA NA 388.9 388.9 390.9 393.2 
 
 
 
Table 2. 14: AIC where all serial intervals are observed regardless of their length. 
Inf=Informative, Less=less-informative, miss=misspecified, LN=Log-normal 
 
Table 2.14a: N1, gamma (2, 0.004)  
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AIC: 
median, 
25th -75th 
percentile 
 
A B C D E F G H 
50 357 
(310-
407) 
365 
(318
-
416) 
357 
(310-
407) 
357 
(310-
407) 
375 
(332-
421) 
382 
(332-
435) 
374 
(325-
427) 
388 
(338-
442) 
200 1425 
(1330-
1522) 
1448 
(135
2-
1548
) 
1425 
(1330
-
1522) 
1425 
(1330
-
1522) 
1426 
(1332
-
1524) 
1505 
(1405-
1609) 
1492 
(1392-
1596) 
1467 
(1366
-
1570) 
500 3565 
(3413-
3720) 
3620 
(346
6-
3775
) 
3565 
(3413
-
3720) 
3565 
(3413
-
3720) 
3566 
(3414
-
3721) 
3750 
(3587-
3914) 
3736 
(3572-
3899) 
3710 
(3546
-
3874) 
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Table 2.14b: N2, gamma (2.5, 0.004) 
AIC: 
median, 
25th -75th 
percentile 
 
A B C D E F G H 
50 365 
(316-
415) 
380 
(331-
432) 
365 
(316-
415) 
365 
(316-
415) 
378 
(332
-
425) 
405 
(353
-
461) 
396 
(343-
452) 
378 
(329-
429) 
200 1454 
(1359
-
1555) 
1500 
(1401
-
1603) 
1454 
(135
9-
1555
) 
1454 
(1359
-
1555) 
1455 
(136
0-
1556
) 
1599 
(149
2-
1710
) 
1587 
(1480
-
1697) 
1554 
(1446
-
1666) 
500 3644 
(3488
-
3799) 
3749 
(3589
-
3908) 
3644 
(348
8-
3799
) 
3644 
(3488
-
3799) 
3644 
(348
9-
3800
) 
3988 
(381
6-
4163
) 
3975 
(3803
-
4150) 
3947 
(3775
-
4123) 
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Table 2.14c: N3, gamma (1.8, 0.003) 
AIC: 
median, 
25th -75th 
percentile 
 
A B C D E F G H 
50 367 
(319-
419) 
375 
(325
-
426) 
368 
(319-
420) 
368 
(319
-
420) 
383 
(337-
431) 
388 
(336
-
441) 
383 
(331-
435) 
397 
(345-
454) 
200 1467 
(1368-
1567) 
1484 
(138
6-
1587
) 
1467 
(1368
-
1568) 
1467 
(136
8-
1568
) 
1468 
(1370-
1569) 
1524 
(142
3-
1629
) 
1512 
(1412
-
1617) 
1497 
(1397
-
1601) 
500 3673 
(3515-
3829) 
3714 
(355
5-
3870
) 
3673 
(3515
-
3829) 
3673 
(351
5-
3829
) 
3673 
(3516-
3829) 
3797 
(363
4-
3958
) 
3781 
(3618
-
3943) 
3760 
(3598
-
3921) 
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Table 2.14d: H1, LN (6, 1) 
AIC: 
median, 
25th -75th 
percentile 
 
A B C D E F G H 
50 375 
(326-
428) 
373 
(325
-
426) 
376 
(328-
429) 
375 
(326-
428) 
389 
(341
-
441) 
376 
(327-
429) 
379 
(330-
432) 
424 
(367-
488) 
200 1503 
(1402-
1607) 
1490 
(139
1-
1593
) 
1503 
(1402-
1607) 
1503 
(1402
-
1607) 
1505 
(140
5-
1609
) 
1494 
(1395
-
1599) 
1498 
(1399-
1602) 
1534 
(1432
-
1644) 
500 3764 
(3602-
3928) 
 
3728 
(356
8-
3889
) 
3764 
(3603-
3928) 
3764 
(3602
-
3928) 
3765 
(360
3-
3929
) 
3733 
(3574
-
3896) 
3736 
(3576-
3899) 
3747 
(3586
-
3911) 
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Table 2.14e: H2, LN (6.3, 1) 
AIC: 
median, 
25th -75th 
percentile 
 
A B C D E F G H 
50 390 
(339-
445) 
388 
(338-
443) 
392 
(342-
447) 
390 
(339
-
445) 
400 
(350-
454) 
391 
(340-
445) 
393 
(342-
448) 
419 
(363-
482) 
200 1563 
(1459-
1671) 
1550 
(1448
-
1657) 
1564 
(1460
-
1672) 
1563 
(145
9-
1671
) 
1565 
(1461
-
1673) 
1554 
(1451-
1661) 
1556 
(1454
-
1665) 
1581 
(1476-
1692) 
500 3915 
(3747-
4085) 
3879 
(3713
-
4046) 
3915 
(3748
-
4086) 
3915 
(374
7-
4085
) 
3915 
(3748
-
4086) 
3883 
(3718-
4051) 
3885 
(3720
-
4055) 
3895 
(3728-
4065) 
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Table 2.14f: H3, LN (6.5, 1) 
AIC: 
median, 
25th -75th 
percentile 
 
A B C D E F G H 
50 400 
(348-
456) 
398 
(347-
454) 
402 
(351-
459) 
400 
(348-
457) 
407 
(356-
463) 
400 
(349-
457) 
403 
(351-
459) 
420 
(364-
481) 
200 1603 
(1496
-
1714) 
1590 
(1486
-
1700) 
1604 
(1499
-
1715) 
1603 
(1496
-
1714) 
1605 
(1498
-
1715) 
1594 
(1488
-
1704) 
1596 
(1491
-
1707) 
1604 
(1497
-
1716) 
500 4015 
(3843
-
4190) 
3979 
(3809
-
4150) 
4016 
(3844
-
4190) 
4015 
(3843
-
4190) 
4016 
(3844
-
4190) 
3983 
(3814
-
4156) 
3985 
(3816
-
4159) 
3993 
(3823
-
4169) 
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Table 2.14g: M1, Gamma and Gamma: (2, 0.004) and (50, 0.01) with probabilities (80%, 
20%)  
AIC: 
median, 
25th -75th 
percentile 
 
A B C D E F G H 
50 412 
(357-
468) 
408 
(353
-
464) 
413 
(358-
469) 
412 
(357
-
468) 
417 
(361-
472) 
431 
(371-
495) 
426 
(367-
490) 
476 
(408-
552) 
200 1648 
(1539-
1762) 
1633 
(152
4-
1747
) 
1648 
(1540
-
1762) 
1647 
(153
9-
1762
) 
1649 
(1542
-
1764) 
1740 
(1614
-
1874) 
1728 
(1602-
1866) 
1871 
(1726-
2030) 
500 4126 
(3949-
4304) 
4091 
(391
3-
4269
) 
4127 
(3950
-
4304) 
4126 
(394
9-
4304
) 
4127 
(3950
-
4305) 
4392 
(4185
-
4603) 
4384 
(4170-
4596) 
4580 
(4348-
4820) 
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Table 2.14h: M2, Gamma and Gamma: (2, 0.004) and (50, 0.01) with probabilities (95%, 
5%)  
AIC: 
median, 
25th -75th 
percentile 
 
A B C D E F G H 
50 378 
(327-
431) 
376 
(326-
427) 
379 
(329-
432) 
378 
(327-
431) 
390 
(341-
442) 
380 
(329-
432) 
383 
(333-
436) 
415 
(358-
476) 
200 1520 
(1415-
1626) 
1498 
(1396
-
1601) 
1521 
(1416
-
1626) 
1520 
(1415
-
1626) 
1523 
(1418
-
1628) 
1505 
(1404-
1609) 
1508 
(1407
-
1612) 
1526 
(1421
-
1634) 
500 3803 
(3644-
3970) 
3743 
(3586
-
3904) 
3803 
(3644
-
3970) 
3803 
(3644
-
3970) 
3804 
(3645
-
3971) 
3755 
(3597-
3917) 
3757 
(3599
-
3920) 
3755 
(3600
-
3918) 
     Notes: Inf=informative prior; Less=less informative prior; Mis=misspecified prior. 
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Table 2. 15: DIC where all serial intervals are observed regardless of their length. 
Inf=Informative, Less=less-informative, miss=misspecified, LN=Log-normal 
 
Table 2.15a: N1, gamma (2, 0.004)  
AIC: 
median, 
25th -75th 
percentile 
 
A B C D E F G H 
50 NA NA 356 
(309-
406) 
357 
(310-
407) 
374 
(331-
421) 
382 
((332-
435) 
376 
(327-
429) 
397 
(346-
453) 
200 NA NA 1424 
(1330-
1522) 
1425 
(1330-
1522) 
1426 
(1332-
1524) 
1503 
(1403-
1607) 
1493 
(1393-
1597) 
1473 
(1373-
1575) 
500 NA NA 3565 
(3413-
3720) 
3565 
(3413-
3720) 
3566 
(3414-
3721) 
3749 
(3585-
3912) 
3736 
(3572-
3899) 
3711 
(3548-
3874) 
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Table 2.15b: N2, gamma (2.5, 0.004) 
AIC: 
median, 
25th -75th 
percentile 
 
A B C D E F G H 
50 NA NA 364 
(315-
414) 
365 
(316-
415) 
378 
(332-
425) 
401 
(349-
458) 
395 
(343-
450) 
385 
(335-
437) 
200 NA NA 1454 
(1358-
1555) 
1454 
(1359-
1555) 
1456 
(1360-
1556) 
1596 
(1489-
1707) 
1585 
(1478-
1696) 
1555 
(1447-
1666) 
500 NA NA 3643 
(3488-
3799) 
3644 
(3488-
3799) 
3644 
(3489-
3800) 
3986 
(3814-
4160) 
3973 
(3801-
4148) 
3946 
(3774-
4121) 
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Table 2.15c: N3, gamma (1.8, 0.003) 
AIC: 
median, 
25th -75th 
percentile 
 
A B C D E F G H 
50 NA NA 367 
(318-
419) 
368 
(319-
420) 
382 
(336-
431) 
386 
(334-
439) 
384 
(333-
437) 
406 
(353-
464) 
200 NA NA 1466 
(1368-
1567) 
1467 
(1368-
1568) 
1468 
(1370-
1569) 
1523 
(1422-
1628) 
1514 
(1413-
1618) 
1505 
(1405-
1609) 
500 NA NA 3672 
(3515-
3829) 
3673 
(3515-
3829) 
3673 
(3516-
3830) 
3796 
(3634-
3958) 
3782 
(3619-
3944) 
3763 
(3600-
3924) 
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Table 2.15d: H1, LN (6, 1) 
AIC: 
median, 
25th -75th 
percentile 
 
A B C D E F G H 
50 NA NA 375 
(326-
428) 
375 
(326-
428) 
388 
(340-
440) 
377 
(328-
431) 
384 
(334-
438) 
436 
(377-
501) 
200 NA NA 1503 
(1402-
1607) 
1503 
(1402-
1607 ) 
1505 
(1405-
1609) 
1497 
(1398-
1601) 
1504 
(1405-
1609) 
1551 
(1448-
1661) 
500 NA NA 3764 
(3602-
3928) 
3764 
(3602-
3928) 
3764 
(3603-
3929) 
3738 
(3578-
3901) 
3743 
(3782-
3906) 
3757 
(3595-
3921) 
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Table 2.15e: H2, LN (6.3, 1) 
AIC: 
median, 
25th -75th 
percentile 
 
A B C D E F G H 
50 NA NA 390 
(340-
446) 
390 
(339-
445) 
399 
(349-
453) 
391 
(340-
446) 
397 
(346-
453) 
429 
(372-
493) 
200 NA NA 1563 
(1459-
1671) 
1563 
(1459-
1671) 
1565 
(1461-
1673) 
1556 
(1453-
1663) 
1562 
(1459-
1671) 
1594 
(1489-
1705) 
500 NA NA 3915 
(3747-
4085) 
3915 
(3747-
4085) 
3915 
(3748-
4086) 
3886 
(3721-
4055) 
3892 
(3726-
4061) 
3904 
(3736-
4074) 
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Table 2.15f: H3, LN (6.5, 1) 
AIC: 
median, 
25th -
75th 
percen 
-tile 
 
A B C D E F G H 
50 NA NA 401 
(349-
457) 
399 
(347
-
456) 
406 
(355-
463) 
401 
(348-
457) 
406 
(354-
463) 
428 
(371-
491) 
200 NA NA 1603 
(1498
-
1714) 
1603 
(149
6-
1714
) 
1605 
(1498-
1715) 
1595 
(1489
-
1705) 
1601 
(1496-
1712) 
1615 
(1508-
1725) 
500 NA NA 4016 
(3844
-
4190) 
4015 
(384
3-
4016 
(3844-
4190) 
3986 
(3817
-
4159) 
3991 
(3822-
4165) 
4002 
(3831-
4177) 
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4190
) 
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Table 2.15g: M1, Gamma and Gamma: (2, 0.004) and (50, 0.01) with probabilities (80%, 
20%)  
AIC: 
median, 
25th -75th 
percentile 
 
A B C D E F G H 
50 NA NA 411 
(356-
468) 
411 
(356-
468) 
415 
(360-
471) 
438 
(378-
504) 
435 
(376-
502) 
490 
(421-
569) 
200 NA NA 1648 
(1539-
1761) 
1647 
(1539-
1762) 
1649 
(1541-
1763) 
1752 
(1625-
1887) 
1741 
(1614-
1879) 
1893 
(1746-
2053) 
500 NA NA 4126 
(3949-
4304) 
4126 
(3949-
4304) 
4127 
(3950-
4304) 
4407 
(4199-
4618) 
4400 
(4186-
4614) 
4603 
(4370-
4844) 
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Table 2.15h: M2, Gamma and Gamma: (2, 0.004) and (50, 0.01) with probabilities (95%, 
5%)  
AIC: 
median, 
25th -75th 
percentile 
 
A B C D E F G H 
50 NA NA 378 
(328-
431) 
378 
(327-
431) 
389 
(340-
441) 
382 
(332-
435) 
387 
(337-
441) 
426 
(367-
489) 
200 NA NA 1520 
(1416-
1626) 
1520 
(1416-
1626) 
1523 
(1418-
1628) 
1509 
(1408-
1613) 
1513 
(1411-
1617) 
1539 
(1434-
1648) 
500 NA NA 3803 
(3644-
3970) 
3803 
(3644-
3970) 
3804 
(3644-
3971) 
3760 
(3602-
3921) 
3763 
(3604-
3924) 
3762 
(3607-
3926) 
Notes for tables 2.14 and 2.15: Inf=informative prior; Less=less informative prior; 
Mis=misspecified prior. 
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Figure 2. 2: Estimated mean SI based on 10,000 simulations when the underlying SI is 
gamma distributed.  
 
Notes: 1) N1: gamma (2, 0.004) with mean 500 days (1.37 years); N2: gamma (2.5, 
0.004) with mean 625 days (1.71 years); N3: gamma (1.8, 0.003) with mean 600 days 
(1.64 years).  
2) 1: MLE gamma parameterization; 2: MLE log-normal parameterization; 3: Bayesian 
informative prior, gamma parameterization; 4: Bayesian less-informative prior, gamma 
parameterization; 5: Bayesian miss-speficied prior, gamma parameterization; 6: Bayesian 
informative prior, log-normal parameterization; 7: Bayesian less-informative prior, log-
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normal parameterization; 8: Bayesian miss-specified parametrization, log-normal 
parameterization. 3) The blue line indicates the true mean SI in days. 
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Chapter 3 Using cure models to estimate the serial interval of tuberculosis with 
limited follow-up 
 
 
3.1 Introduction 
 
The serial interval (SI), defined as the time between symptom onset of an infector and 
infectee pair, is commonly used to understand infectious disease transmission dynamics 
[89]. It is typically used as an approximation of the more biologically relevant generation 
interval—the time between the (unobserved) point of infection in an infector and its 
infectee. Assuming that the time between infection and onset of symptoms is independent 
and identically distributed, the SI is an unbiased estimator of the generation interval. This 
value, coupled with the reproductive number (the average number of secondary cases 
generated per case), is important in understanding how rapidly an infectious disease 
might spread through a population and is frequently used in modeling studies of 
infectious diseases [10–16].  
 
The SI is often estimated from observed data as the mean or median of the observed (or 
reported) time between symptom onset in infector and infectee pairs [10], which are often 
determined using contact tracing. Serology or genetic information is frequently 
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incorporated to increase the probability of identifying a correct linkage [33]. In diseases 
with a relatively short infectious period, it is reasonable to assume that all SIs can be 
observed with adequate follow-up and detailed contact tracing. Then one can estimate the 
entire SI distribution using basic maximum likelihood estimation and a model fit criteria 
(such as the Akaike Information Criteria [AIC]) to choose among potential parametric 
distributions, such as the gamma, lognormal or exponential [15,90,91]. Modifications to 
account for truncation [90], the discreteness of data traditionally collected [91], and 
interval censoring [92] have been described elsewhere. Additionally, nonparametric 
methods have been proposed to estimate survival curves and are readily applicable to this 
problem [90,93,94].  
 
Estimation of the serial interval for tuberculosis (TB) is complicated by two additional 
factors. Firstly, in contrast with diseases such as influenza, there can be a long latent 
period (of potentially years) between infection with Mycobacterium tuberculosis (Mtb), 
the causative agent of TB, and the development of TB symptoms. Due to the long disease 
latency, it is not typically feasible to follow all contacts of an infectious case long enough 
to determine if they develop disease, and one should consider infected contacts of a TB 
case as right censored (i.e. having left the study before the event occurred). Secondly, the 
lifetime risk of developing symptomatic TB disease, given initial infection, is estimated 
to be 5-10% [4]. However, survival analysis methods assume that all the “censored” 
individuals will eventually experience the event of interest, which is clearly not the case 
when the event of interest is development of TB disease. This assumption is therefore 
  133 
violated and could lead to substantial bias in the resulting estimate of the SI for TB 
[4,45,95].   
 
Here, we show how one can use cure models, first proposed by Boag in 1949 [83], to 
estimate the SI (or any parametric survival curve) when those who have not experienced 
disease by the end of follow-up are not all still at risk of developing disease. We illustrate 
through simulations the limitations of this approach and the assumptions needed to 
implement it and apply these methods to TB studies data.  
 
3.2 Methods 
 
3.2.1 Statistical methods 
 
We first describe a naive approach using only the observed serial intervals and discarding 
information on all individuals who did not develop disease. Denote the observed serial 
intervals by , 1, 2,3,...,ix i n . The joint likelihood function is: 
1 2
1
                      ( | , ,..., ) ( | )                                                             (3.1)
n
n i
i
L x x x f x 

  
where   is the parameter space in a parametric distribution and ( | )if x    is the 
probability density function (pdf). We consider either the gamma or lognormal 
distribution [15,20,24,44,90,96]. To estimate  , we can either use a Maximum 
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Likelihood Estimation (MLE) approach or a Bayesian approach using Markov Chain 
Monte Carlo (MCMC) sampling.  
 
The limitation of the naive method is the assumption of having observed all the SIs, 
which is unlikely due to insufficiently long follow-up as described previously. The 
standard approach for accounting for this censoring in the data is to modify the likelihood 
by dividing the entire dataset between those who had an observed SI and those who did 
not, which assumes that all individuals eventually develop the disease of interest [97] but 
due to follow-up being too short or individuals being lost to follow-up we fail to observe 
all the serial intervals. Here, we let id  be the censoring indicator for person i  where id
=1 if the SI is observed; id =0 if the SI is censored. The joint likelihood function is:  
1 1
     ( ) ( | ) ( | ) ( | )                                              (3.2)i
n n
d
i i i
i i
L L x x S x    
 
    
where 
( | )
( | )
1 ( | )
f x
x
F x

 



 and ( | ) 1 ( | )S x F x   . Here, ( | )f x   and ( | )F x   are 
the probability density function (pdf) and cumulative distribution function (CDF) for the 
SIs. Again MLE or MCMC approaches to estimation are appropriate.  
 
As noted, a key assumption that all individuals will eventually experience the event of 
interest is violated in TB studies. A similar situation occurs in cancer where many 
individuals experience cure after treatment and survival models to describe the time to 
relapse must incorporate the probability of cure [98]. The “cure model” was developed 
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for this problem and adds an additional parameter to capture the probability of a person 
having the event of interest (e.g. developing active disease),                                        p , to the likelihood function 
which becomes 
1
1
       ( , ) {  ( | ) } {  ( | )  (1 ) }                                                 (3.3)i i
n
d d
i i
i
L p p f x p S x p   

    
with id , ( | )f x  and ( | )F x  are  defined as before. As censoring is present in the data, 
the 'ix s are either the observed SIs for those who develop TB disease before the end of 
the study or the total time that a censored individual is followed. The parameter                                        p is for 
the probability of developing disease and 1 p  is the probability of being “cured”. The 
introduction of this parameter creates a problem of identifiability and without additional 
data, standard maximum likelihood estimation will struggle to simultaneously estimate 
this parameter and the parameters of the SI estimation accurately. One approach to this 
problem is to use existing literature and fix                                        p at a value, for instance 0.10 for TB. 
However, without strong information on this parameter, we risk biasing the estimate. In 
the past, since this quantity is not observable, it has been estimated using the EM 
algorithm [99]. A less heavy-handed approach is to use Bayesian estimation techniques 
where the Markov Chain Monte Carlo method is used [100]. For TB, we can use an 
informative prior for                                        p based on information from the literature. Since 0≤ p ≤1, a beta 
distribution is appropriate and can be centered at a value that is identified from existing 
literature. For the case of TB we might use a beta distribution for the prior centered 
around a value between 0.05 and 0.10, based on [4].   
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Othus [98] suggested that a survival curve that plateaus toward the end of study may 
suggest that a certain fraction of the study population is “cured” and therefore never 
experiences the event of interest, indicating the appropriateness of a cure model. We 
evaluate the survival curve in both simulated and real data to determine the 
appropriateness of the cure model. 
 
Household contact studies are popular for studying TB transmission and may contain 
information that can be used to estimate the serial interval [45]. The exact time of 
symptoms developing is not easily observed so the diagnosis date of TB disease is used 
as a surrogate. TB cases diagnosed proximate to their index case are sometimes defined 
as “co-prevalent”—the transmission between the index case and the secondary case is 
questionable due to the short time period and therefore the serial interval might be 
excluded [101].  We conduct sensitivity analysis when analyzing the real data by 
excluding co-prevalent cases within 30 days or 90 days of their index cases. When 
excluding co-prevalent cases using 30 days, the SI, denoted by x , is defined as: 
0,                              30 days    
                     g( | )                                    (3.4)
( 30 | ),            30 days
if x
x
f x if x



 
 
 
where ( | )f x    is the parametric density (for example, gamma) we use to estimate the SI. 
A similar strategy is applied using 90 days. 
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3.2.2 Simulation study 
 
We simulate data to mirror TB household contact studies and to test the performance of 
the cure model under a variety of circumstances. Within each simulation, we simulate 
3%, 10%, 50%, 80% of the entire population to develop TB disease. The first two of 
these four scenarios are consistent with TB, while the latter two are included to better 
understand the behavior of cure models more generally. Based on the limited estimates 
for the SI of TB [96], the SI for each simulated individual who is not cured is drawn from 
a gamma distribution with a mean of 1.4 years and a median of 1.1 years. We also 
consider a lognormal distribution with a mean of 3.0 years and a median of 1.8 years. For 
those who develop active TB disease, we use three censoring mechanisms: 1) SIs are all 
censored at year 1, 2) SIs are all censored at year 2, and 3) SIs are censored randomly 
between 2-5 years. This means that an individual who is not cured and has a simulated SI 
of 2.5 years would be censored in scenarios 1) and 2), but may or may not be censored in 
scenario 3). We run 1000 simulations using STAN [102] in R using the “rstan” package 
for each scenario. 
 
We estimate the SI in the simulated data using 3 methods: a) the naive approach using the 
likelihood function in (1), b) the traditional survival approach using the likelihood 
function in (2), and c) the cure model approach using the likelihood in (3).  In all three 
approaches, the SI estimates are summarized by posterior distributions of the parameters, 
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which are approximated by MCMC sampling. In the cure model approach, the additional 
parameter                                        p is estimated using different prior distributions. For example, when the true 
disease rate is 3%, a flat prior for                                        p is beta (1,1) (mean 0.5, median 0.5) which puts equal 
weights on probabilities between 0 and 1; an informative prior for                                        p is beta (0.2, 5) 
(mean 0.04, median 0.005) which puts more weights on lower probabilities; a 
misspecified prior for                                        p is beta (5, 1) (mean 0.8, median 0.8) which puts more weights on 
higher probabilities. 
 
To evaluate the performance of the different approaches for estimation, we evaluate the 
bias of each estimator as well as the Mean Squared Error (MSE). More details on the 
simulations are in the appendix. 
 
3.2.3 Datasets 
 
The first dataset is from Vitoria, Brazil, 2008-2013 [103], which enrolled 160 index cases 
who had active TB disease, identified through routine surveillance, and 958 individuals 
living in the same households as these index cases. Of the 958 household contacts, 47 
developed active TB disease during follow-up, ranging between 2 to 6 years.  
 
The second dataset is from the United States and Canada, 2002-2006 [104], which 
enrolled 718 index cases and 4490 contacts of whom 158 developed active TB disease 
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during the 4-year follow-up period. 
 
Both studies assumed that all TB disease was transmitted from the index cases to 
diagnosed contacts and used diagnosis date as a surrogate for disease onset. We assume 
that the time from onset to diagnosis is independent and identically distributed for index 
cases and household contacts in order to estimate the SI.  
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3.3 Results 
 
3.3.1 Simulation results 
 
In the simulations, the traditional survival model estimates were extremely biased when 
the disease rate was low (Figure 3.1 and Table A.3.2). The naive approach consistently 
underestimated the SI, although the underestimation was minimal with adequate follow-
up (Figure 1). The cure model produced relatively unbiased results when the disease rate 
was low and censoring occurred relatively late (Figure 1). The bias for the cure model 
decreased as the disease rate increased from 3% to 80%, regardless of the specification of 
the prior for                                        p .  
 
The survival curves appear to be a useful indicator of the applicability of the cure model. 
The survival curve tended to plateau toward the end of follow-up when censoring 
occurred between 2 and 5 years for all disease rates (Figure 3.2). This phenomenon was 
most apparent for lower disease rates (3% and 10%), which was consistent with the cure 
model performing well in these scenarios. Results were insensitive to the specification of 
the SI (gamma versus lognormal). 
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3.3.2 Real data results 
  
For the Brazil data, the naive approach yielded an estimated SI of 1.5 years (95% credible 
interval: 1.1-2.1) and with the traditional survival approach, the SI was estimated at 584 
years (95% credible interval: 244-2016). The survival curve appeared to plateau toward 
the end of the study, suggesting the appropriateness of a cure model (Figure 3.3). Using 
the cure model approach with a flat prior (beta (1, 1), which put equal weights between 0 
and 1 for the probability of disease, the SI was estimated at 2.2 years (95% credible 
interval: 1.2-17.1), and the probability of disease was estimated at 0.06 (95% credible 
interval: 0.05-0.14). Using the same approach with an informative prior (beta (0.2, 5) 
with mean 0.04 and median 0.005), the SI was estimated at 2.1 years (95% credible 
interval 1.3-9.4), and the rate of disease was estimated at 0.06 (95% credible interval: 
0.05-0.10). Sensitivity analysis showed that when excluding cases with short SIs (either 
less than 30 or 90 days), the cure model yielded similar estimated SIs and probability of 
disease (Table A.3.2). 
 
For the USA/Canada data, the naive approach yielded an estimated SI of 0.52 years (95% 
credible interval: 0.43-0.64) and with the traditional survival approach, the SI was 
estimated at 28,496 years (95% credible interval: 10,033-129,651). The survival curve 
did not appear to plateau toward the end of the study, suggesting that the cure model may 
not be necessary (Figure 3.4) and the naive approach was sufficient. Using the cure 
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model with a flat prior for the probability of disease, the SI was estimated at 0.51 years 
(95% credible interval: 0.41-0.62), and the probability of disease was estimated at 0.03 
(95% credible interval: 0.02-0.03). Using the same approach with an informative prior 
did not alter the results (mean SI 0.51 years, 95% CI 0.41-0.64, p=0.03, 95% CI: 0.02-
0.04). Sensitivity analysis showed that when excluding cases with short SIs (either less 
than 30 or 90 days), the cure model yielded a lower estimated rate of disease and a longer 
estimated SI (Table A.3.3). 
 
 
Figure 3. 1: Bias of mean serial interval, censored at year 1, year 2 and years 2-5 
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surv: survival approach, mis: misspecified prior in a cure model, flat: flat prior in a cure 
model, inf: informative prior in a cure model, naive: naive approach. Large biases not 
shown in this figure are: 1) censor at year 1, 3%, survival approach with bias 4826; 2) 
censor at year 2, 3%, survival approach with bias 15215 and misspecified prior in the 
cure model with bias 12224; 3) censor at year 2, 10%, survival approach with bias 5875; 
4) censor at year 2-5, 3%, survival approach with bias 65862 and misspecified prior in 
the cure model with bias 37671; 5) censor at year 2-5, 10%, survival approach with bias 
19149. 
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Figure 3. 2: Survival curve (probability of not developing active TB disease) from first 
200 of the 1000 simulated datasets with true disease rates 3%, 10%, 50%, 80% and 
censoring occurring at year 1, year 2 and between 2-5 years; time in years. 
 
 
Figure 3. 3: Probability of not developing TB disease over time, based on the data from 
the Brazil study (“survival curve”, time in years) 
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Figure 3. 4: Probability of not developing TB disease over time, based on the data from 
the USA/Canada study (“survival curve”, time in years) 
 
3.4 Discussion 
 
When estimating serial intervals for an infectious disease, one must consider issues with 
incomplete follow-up and the potential for infected individuals to self-cure. In simulation 
studies, we show that results from the naive approach are biased, tending to 
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underestimate the mean of the SI. Traditional survival techniques are inappropriate as 
they assume that all individuals are at risk of the disease, which is not the case if the 
survival curve plateaus before reaching zero. We show that cure models, when used in 
the presence of credible information on the cure rate (the proportion of individuals who 
never experiences the event of interest) can lead to less biased estimates in scenarios 
where the cure rate ranges from 97% to 20%. We show that the impact of applying these 
models to estimation of the SI using real data from Brazil and the US/Canada. 
 
We found via a simulation study that in the setting of TB, the naive approach, which only 
analyzed the observed serial intervals, consistently underestimated the SI, although the 
underestimation was minimal with sufficient follow-up. To address issues of inadequate 
follow-up and censoring, we proposed to use a cure model and tested this approach on 
multiple disease rates and multiple censoring mechanisms.  We found that when the 
disease rate was low, the cure model performed well (lower bias, MSE) when the 
censoring occurred relatively late to allow sufficient observed SIs, or when we had 
correct prior information on the probability of disease. We also found that, when the 
disease rate increased from 3% to 80%, the cure model performed well regardless of the 
censoring mechanisms. 
 
Othus [98] suggested that a survival curve that plateaus toward the end of study may 
indicate the appropriateness of a cure model, which agrees with what we found in the 
simulations: when the disease rate was low and censoring occurred later, the cure model 
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performed well with low bias and MSE (Figure 3.1). This is also consistent with the real 
data results. In the Brazil [103] dataset, the survival curve indicated that the cure model 
may be appropriate, and therefore the cure model approach yielded a larger estimated SI 
compared to the naive approach, which only analyzed observed SIs. In the USA/Canada 
[104] dataset, the survival curve did not show a need for the cure model. In this case, the 
cure model yielded similar results to the naive approach. We recommend that in the 
presence of prior information on the disease rate, especially when the disease rate is low, 
one should consider using a cure model instead of a traditional survival approach with an 
informative prior being used for the cure rate. The survival curve can be a useful tool to 
determine whether a cure model should be used. 
 
The US/Canada dataset yielded a lower SI (0.5 years) than the Brazil dataset (around 2 
years). This may imply a higher occurrence of reinfection TB in a developing country 
like Brazil [105]. In the case of reinfection TB, latently infected individuals can become 
infected again by another strain of Mtb and develop active disease, resulting in, what 
appears to be, longer SIs. It is currently not possible to differentiate between different 
strains of latent TB, thus limiting our ability to understand the SI and true dynamics of 
transmission.  
 
Accurate estimates of the SI are important in understanding the transmission dynamics of 
an infectious disease, for informing modeling studies and understanding the length of 
time that a latently infected individual is most likely to be at risk of developing active 
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disease. Our understanding of this quantity is limited for TB [96] and in this paper we not 
only provide estimates of this quantity for two geographic settings, but also provide a 
general approach for obtaining estimates of the SI that can be applied to other settings.  
 
There are important limitations in this paper. First, we do not have access to molecular 
data, which would potentially allow us to better determine if cases are in fact linked by 
transmission. We make a simplifying assumption that those who are in a household did in 
fact transmit to each other. However even with this data, it would not necessarily clarify 
issues from reinfection. This is a clear limitation as substantial transmission outside the 
household, particularly in high burden settings, has been demonstrated [106]. 
Additionally, due to limitations in TB diagnostics, we are unable to determine if 
individuals are being reinfected with TB. This could either elongate the SI estimates if 
the true infector developed symptoms after the index case in the study data we use or 
could shrink it if an individual was infected again after the index case exposure. The 
results we present from the US/Canada study, where TB burden is low, would seem to 
indicate that we are likely overestimating the SI in higher burden settings. Further 
molecular testing and improved diagnostics will increase our understanding of this 
important transmission dynamic. 
 
As 2035 approaches – the year designated by the WHO’s ENDTB strategy as the goal for 
reducing TB incidence by 90% [1] - we urgently need to rethink how we measure 
progress towards this goal. Few studies have estimated the SI and those that have 
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attempted this have focused on naive methods [96]. Improved methods to estimate the SI 
could help identify locations that require focused interventions to reduce TB incidence 
and meet the ENDTB goals and inform TB modeling studies, providing better 
understanding of the efficacy of potential interventions and policies. 
 
3.5 Appendix 
 
Our simulation structure is intended to mirror TB household contact data. We simulate a 
total of 200 households. For each household, a random number household contacts is 
drawn from a Poisson distribution with mean six. The choice of this Poisson parameter is 
consistent with empirical data [103]. Within each simulation, we simulate 3%, 10%, 
50%, 80% of the entire population to develop TB disease within the study period and 
have their serial intervals observed. The first of these are consistent with TB, while the 
latter two are included to better understand the behavior of cure models more generally. 
The serial interval for each simulated individual who is not cured is drawn from a known 
gamma distribution with shape 2 and rate 0.004 with a mean of 1.4 years and a median of 
1.1 years. 
 
For those who develop active TB disease, we propose three censoring mechanisms: 1) 
serial intervals are all censored at year 1; 2) serial intervals are all censored at year 2; 3) 
serial intervals are censored randomly between 2-5 years. This means that an individual 
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who is not cured and has a simulated serial interval of 2.5 years would be censored in 
scenarios 1) and 2), but may or may not be censored in scenario 3). 
 
For each scenario, we run 1000 simulations. All simulations were run in R and estimation 
was performed using STAN [102] using the “rstan” package in R. We use trace plots, 
autocorrelation plots and Gelman and Rubin’s method [107] to examine sampler 
convergence. 
 
As stated in the main text, we use three estimation approaches. The naive approach only 
makes use of those observed serial intervals and ignores the rest of the data. This is the 
approach that is traditionally taken and is appropriate if there is no censoring in the data. 
The censoring approach uses the likelihood given in (3.2) and assumes that all individuals 
with unobserved disease onset are censored. The cure model uses the likelihood given by 
(3.3), incorporating all features of the data. 
An example of the simulated data is as follows (Figure A.3.1). 
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Figure A.3 1: Person time (either time to disease or time to censoring) in a simulated 
dataset with 200 households and censoring occurring at year 2 with 50% disease rate. 
 
In the simulations, we evaluate different prior distributions for the probability of disease 
p, as this information can be obtained from the literature [4]. For example, when the true 
disease rate is 3%, a flat prior for                                        p is beta (1,1) (mean 0.5, median 0.5) which puts equal 
weights on probabilities between 0 and 1; an informative prior for                                        p is beta (0.2, 5) (mean 
0.04, median 0.005) which puts more weights on lower probabilities; a misspecified prior 
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for                                        p is beta (5, 1) (mean 0.8, median 0.8) which puts more weights on higher 
probabilities. For a full list of prior distributions for different underlying disease rates, see 
Table 3.1. 
 
Table 3. 1: Prior distributions for the probability of disease. 
 
True 
disease 
rate 
Flat prior Informative prior Misspecified prior 
Distribution, 
mean, median 
Distribution, 
mean, median 
Distribution, 
mean, median 
3% beta (1, 1), 
0.5, 0.5 
beta (0.2, 5), 
0.4, 0.004 
beta (5, 1), 0.8, 0.8 
10% beta (1, 1), 
0.5, 0.5 
beta (0.8, 5), 
0.14, 0.10 
beta (5, 1), 0.8, 0.8 
50% beta (1, 1), 
0.5, 0.5 
beta (50, 50), 0.5, 
0.5 
beta (0.5, 0.5), 0.5, 0.5 
80% beta (1, 1), 
0.5, 0.5 
beta (5, 1), 0.8, 0.8 beta (0.2, 5), 0.4, 
0.004 
 
To evaluate the performance of the different approaches for estimation we evaluate the 
bias of each estimator as well as the Mean Squared Error (MSE). For the bias, we first 
use boxplots to examine the estimated mean or median serial intervals and then compute 
  153 
the bias m in each estimator in the 1000 simulations as: 
1000
1
1
ˆ*
1000 i
m  

  , where ˆ is 
the estimated mean or median, and  is the true mean or median serial interval. The MSE 
is calculated as 
2ˆ( )
ˆ( ) ,  1,2,...,1000
j
j j
j
MSE j
n
 


   where   is the true mean of the 
serial interval and 
jn  is the sample size in the jth simulation run. This is calculated for 
each of the 1000 simulation runs in each scenario, and will be summarized as a 
distribution with median, 1st and 3rd quantile. 
 
 
Simulation results 
The bias plots are shown in Figures A.3.2-A.3.4. The MSE results are shown in Table 
A.3.1.  
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Figure A.3 2: Bias of mean serial, censored at year 1 
surv: survival approach, mis: misspecified prior in a cure model, flat: flat prior in a cure 
model, inf: informative prior in a cure model, naive: naive approach. 
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Figure A.3 3: Bias of mean serial, censored at year 2 
 surv: survival approach, mis: misspecified prior in a cure model, flat: flat prior in a cure 
model, inf: informative prior in a cure model, naive: naive approach. 
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Figure A.3 4: Bias of mean serial, censored at years 2-5 
surv: survival approach, mis: misspecified prior in a cure model, flat: flat prior in a cure 
model, inf: informative prior in a cure model, naive: naive approach.
Table A.3. 1: Mean Squared Error (MSE) for 3%, 10%, 50%, 80% disease rate 
 3% 10% 50% 80% 
Method MSE, 
median, 1st 
and 3rd 
percentile 
MSE, 
median, 1st 
and 3rd 
percentile 
MSE, 
median, 1st 
and 3rd 
percentile 
MSE, 
median, 1st 
and 3rd 
percentile 
Censor at year 1    
Flat 75 (31-154) 47 (15-137) 8 (2-20) 2 (0.4-7) 
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Informative 55 (29-78) 55 (29-78) 1 (0.1-1.9) 1 (0.3-4) 
Misspecified 11660 
(5857-
25640) 
3788 (2625-
5818) 
13 (3-31) 15 (10-23) 
Survival 15870 
(7455-
35340) 
5828 (4005-
8854) 
178 (142-
224) 
12 (8-18) 
Censor at year 2    
Flat 21 (6-87) 7 (2-19) 1 (0.3-3.5) 1 (0.1-2) 
Informative 11 (3-25) 6 (1-14) 0.7 (0.1-1.9) 1 (0.2-2) 
Misspecified 128500 
(77810-
218000) 
15590 
(9452-
21310) 
1 (0.3-3.4) 1 (0.2-2) 
Survival 193700 
(117000-
335000) 
33550 
(25690-
44620) 
508 (445-
579) 
31 (26-37) 
Censor at years 2-5    
Flat 4 (1-10) 1 (0.3-3.7) 0.2 (0.05-
0.64) 
0.2 (0.04-
0.30) 
Informative 3 (1-10) 1 (0.3-3.6) 0.7 (0.1-1.9) 0.1 (0.04-
0.30) 
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Misspecified 1575000 
(676100-
2845000) 
1 (0.3-3.8) 1 (0.3-3.4) 0.1 (0.04-
0.41) 
Survival 3818000 
(2334000-
6208000) 
355700 
(269800-
478500) 
508 (445-
579) 
97 (84-111) 
 
Table A.3. 2: Sensitivity analysis results for Brazil data 
 Estimated serial interval Estimated probability of 
disease (for cure models 
only) 
A B C D A B C D 
All data 1.5 
(1.07-
2.11) 
584 
(243.8
-
2016.0
) 
2.2 
(1.23-
17.10) 
2.1 
(1.28
-
9.37) 
NA NA 0.06 
(0.047
-
0.141) 
0.06 
(0.045
-
0.102) 
Exclude 1-
month co-
prevalent 
cases 
4.9 
(4.48-
5.43) 
293 
(129.5
-
1466.0
) 
2.0 
(1.35-
5.93) 
2.0 
(1.36
-
4.14) 
NA NA 0.06 
(0.041
-
0.096) 
0.06 
(0.04-
0.078) 
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Exclude 3-
month co-
prevalent 
cases 
4.9 
(4.44-
5.46) 
197 
(87.0-
585.9) 
2.3 
(1.60-
5.97) 
2.2 
(1.57
-
4.04) 
NA NA 0.05 
(0.036
-
0.092) 
0.05 
(0.03-
0.068) 
Notes: all serial intervals are in years. A: naive approach; B: survival analysis; 
C:cure models with flat prior; D: cure models with informative prior 
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Table A.3. 3: Sensitivity analysis results for USA/Canada data 
 Estimated serial interval Estimated probability of 
disease (for cure models 
only 
A B C D A B C D 
All data 0.5 
(0.4-
0.6) 
28496 
(10033-
129651) 
0.5 
(0.4-
0.6) 
0.5 
(0.4-
0.6) 
NA NA 0.03 
(0.02
-
0.03) 
0.03 
(0.02-
0.03) 
Exclude 
1-month 
co-
prevalent 
cases 
0.8 
(0.7-
1.1) 
8665 
(2597-
51027) 
0.9 
(0.7-
1.2) 
0.9 
(0.6-
1.2) 
NA NA 0.02 
(0.01
-
0.02) 
0.02 
(0.01-
0.02) 
Exclude 
3-month 
co-
prevalent 
cases 
1.5 
(1.1-
2.0) 
1357 
(364-
8797) 
2.0 
(1.3-
15.3) 
1.8 
(1.3-
5.2) 
NA NA 0.01 
(0.01
-
0.03) 
0.01 
(0.01-
0.02) 
Notes: all serial intervals are in years. A: naive approach; B: survival analysis; C:cure  
models with flat prior; D: cure models with informative prior 
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Chapter 4 Addressing doubly censoring in estimating the serial interval for 
tuberculosis 
 
4.1 Introduction 
 
As stated previously, the serial interval (SI) is defined as the time between disease 
symptom onset of a case (time point B, Figure 4.1) and that of its infector (time point A, 
Figure 4.1): SI=B-A. Due to the slow transmission dynamics of tuberculosis (TB), we 
often do not observe either A or B accurately. For example, patients may not seek 
medical assistance immediately after symptoms develop and diagnosis may require 
laboratory processing time which causes delay in establishing the diagnosis [108].  In 
Figure 4.1, instead of observing the exact time points A and B, we observe intervals 
( , )a aL R and ( , )b bL R  for each subject. In this setting, aL represents the earliest point 
when we think an infector might have started to feel sick; 
aR is when the infector gets 
diagnosed with TB disease. bL and bR are the corresponding time points for the infected 
person. The true time points of symptom onset (A and B) occur sometime in the intervals 
defined by ( , )a aL R  and ( , )b bL R . We refer to these types of data as doubly interval 
censored data. 
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Figure 4. 1: Doubly censored data. Time point A, which falls in observed interval 
( , )a aL R , represents the time of symptom onset in the infector.  
 
For example, aL  can be some time before the infector started to feel sick and aR  can be 
when the infector gets diagnosed with TB disease. Time point B and observed interval 
( , )b bL R are similarly defined for the infected person.  
 
The doubly censored data was first discussed by Turnbull in 1976 [93] where a self-
consistency algorithm was developed. Reich et al. [92] derived a likelihood function 
based on a double integral to obtain the contribution to the likelihood function from all 
possible values of the coarsely measured data. In the method by Reich [92], the double 
integral was simplified into a single integral by using a uniform distribution for time 
point A. Other authors have used the same likelihood function with different distributions 
for time point A and the time between A and B. For instance, Kiani and Arasan [109] 
used an exponential distribution for both time point A and the time between A and B. 
Loh [110] used a uniform distribution for time point A and a log-logistic distribution for 
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the time between A and B. Furthermore, midpoint imputation has been used in [111,112] 
and shown to be reasonably adequate for the special case when intervals have a width of 
2 years or less and the median of the time between A and B was approximately 10 years 
[113]. 
 
In this paper, we introduce a computational approach to relax the distributional 
assumption of time point A in the likelihood function used by Reich et al. [92]. We 
illustrate the performance of this method in a simulation study and apply this method on 
data from Brazil [88]. 
 
 
4.2 Methods 
 
4.2.1 Statistical methods 
 
4.2.1.1 Methods by Reich et al.  
 
Reich et al. [92] show that given a doubly interval-censored observation 
( , , , )a a b bx L R L R , the likelihood to describe the time interval between two points, A and 
B in the intervals is 
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                   ( , ; ) ( )* ( )                                                 (4.1)      
a b
a b
R R
L L
L x h a f b a db da       
where ( )h a is the density for time point A and ( )f b a   is the density for the interval 
between points A and B. In the case of a tuberculosis transmission event, A and B are the 
times of symptom onset in an infector-infectee pair and their difference, the serial 
interval, is the quantity of interest and described by ( )f b a  . Intervals ( , )a aL R and 
( , )b bL R are the observed lower and upper bounds for A and B, respectively.  
 
To calculate the double integral, Reich et al. used a uniform distribution for ( )h a and 
with the substitution of t b a  , the likelihood in (4.1) becomes 
                    ( ) ( )                                                                                    (4.2)f t w t dt

  
where ( )w t is a weight function defined by the observed intervals ( , )a aL R  and 
( , )b bL R .This is referred to as “doubly” interval censoring if ( )w t is defined as shown in 
Figure 4.2, meaning that more weights are given to the central values between 
b aR R  
(the difference of the upper bounds of the two observed intervals) and 
b aL L  (and the 
difference of the lower bounds of the two observed intervals) . The values close to the 
extreme values are given less weight. It is referred to as “reduced” interval censoring if 
( )w t is defined as shown in Figure 4.3. In this case, equal weights are assigned to all the 
values between the maximum and minimum possible values for the serial interval. 
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Figure 4. 2: (a) Doubly censored data with the corresponding weight function shown in 
(b). 
 
Figure 4. 3: (a) Illustration of interval-reduced data; (b) weight function for interval-
reduced data. 
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4.2.1.2 Relaxation of the uniformity assumption 
 
As Reich et al. mentioned in [92], the uniform distribution may not be appropriate when 
there is prior knowledge to indicate against uniformity. For TB, it has been reported that 
the interval ( , )a aL R can be relatively long compared to the serial interval [88,96,114] as 
people likely have been sick for a while by the time they get diagnosed. Moreover, the 
uniform distribution assumption may become questionable when the true symptom onset 
time is likely to skew closer to aL  rather than the point of diagnosis, aR . We can consider 
using different distributions such as a gamma or lognormal for ( )h a in (4.1) to allow for 
skewness imposed by delays in being diagnosed. For the serial interval, ( )f t b a  , we 
can also use the gamma or lognormal distributions as well [96]. Using these distributions 
means that the double integral in (4.1) cannot be solved explicitly. We propose to first 
explicitly solve the first layer of the double integral and use a Riemann sum to 
approximate the second layer of the double integral. Specifically: 
 
                   ( , ; ) ( )* ( )   =   ( ) ( )    
                                   =   ( )*[ ( - )- ( - )] .                                   
a b a b
a b a b
a
a
R R R R a
L L L L a
R
b b
L
L x h a f b a db da h a f t dt da
h a F R a F L a da
   

 


    
              (4.3)                                                          
 
Now, we approximate the integral in (4.3) using the Riemann sum. This is done by first 
dividing the finite interval ( , )a aL R into m small intervals of equal length such that aL =
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0x < 1x < 2x <…< nx < aR . Denote 1-i i ix x x   and 
*
1[ , ]i i ix x x , then 
* *
|| || 0 1 1
            ( )*[ ( - )- ( - )]  =  ( ) ( )          (4.4)lim
a
a
m mR
b b i i i i
L
x i i
h a F R a F L a da g x x g x x
   
     
 
where function g is the integrand of ( )*[ ( - )- ( - )]b bh a F R a F L a . 
 
4.2.1.3 Using weights to improve algorithm efficiency and account for the skewness in 
the intervals 
 
Estimation using Riemann sums can be computationally expensive. We propose a 
modification to improve the efficiency of the algorithm by leveraging existing 
information on the shape of ( )h a . In estimating the serial interval for TB, it is 
reasonable to consider that the unobserved time point A may be closer to the lower bound 
aL  of the observed interval ( , )a aL R . That is, symptom onset time A may be closer to aL  
which is the time that the infector starts to feel sick. We refer to this scenario as “left 
skewed”. As the approximation in (equation 4.4) puts equal weights on the values in 
interval ( , )a aL R , in the presence of prior knowledge on the “skewness” of the interval, 
we propose to assign weights on the possible values in ( , )a aL R . Specifically, if we have 
reason to believe that A is more likely to be in the lower third of the interval, we can use 
this information by specifying a (30%, 70%) weighting to allow more emphasis on the 
part of the interval that we believe to have more information. In other words, for the 
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partition aL = 0x < 1x < 2x <…< mx < aR , we retain every x for the first 30% of the interval, 
[ , ( )*30%]a a a aL L R L  . For the second half of the interval, [ ( )*30%,  ]a a a aL R L R  , 
we retain every third x . As shown in Figure 4.4, when we have reason to believe that the 
interval is “left skewed”, we divide the interval into two parts where every area is 
retained in the first 30% of the interval. Then, every third area of the remaining 70% of 
the interval is retained. A similar strategy can be used with a (10%, 90%) weighting, 
which correspond to a case where we have even stronger reasons to believe that the 
intervals are “skewed”: the unobserved time point A being closer to either its upper or 
lower bound. These weights are determined arbitrarily based on prior knowledge before 
seeing the data. We denote the approximating approach using (30%, 70%), (10%, 90%) 
as weights as “Rie30” and “Rie10”, respectively. 
  169 
 
Figure 4. 4: Approximation method using Riemann sums with weights for left skewed 
data. 
Footnote: the red horizontal line splits the interval into two parts; the shaded area is what 
participates in the summation in equation (4.4). 
 
We propose another approach to use prior knowledge of the skewness of the intervals to 
help reduce the computing time in the approximation method using Riemann sums. As 
shown in Figure 4.5, we again divide the observed intervals into two parts as we do in 
methods “Rie30” and “Rie10”. Instead of taking every third area of the part of the 
interval that we believe is less important, we combine every 3 areas in that part of the 
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interval to simplify the summation in equation (4.4). We denote this grouping approach 
for approximation by “Rie30_lp” when we split the interval into 30% and 70%; we 
denote this approach by “Rie10_lp” when we split the interval into 10% and 90%. 
 
 
Figure 4. 5: Approximation method using Riemann sums with grouping for left skewed 
data. 
 
Once the weights and the grouping strategy are specified, the likelihood contribution 
from each subject x is determined (equation 4.4). Then, the joint likelihood of the data 
1 2, ,..., nx x x is 
  171 
1 2
1
                ( ; , ,..., ) ( )                                                                       (4.5)
n
n j
j
l x x x f x

  
where 
*
1
( ) = ( ) 
m
j i i
i
f x g x x

  as defined in (equation 4.4). Here, index j is for the data 
points and i is for indexing the partition in the approximation method for each data point. 
Estimates for parameter space can be obtained by using standard maximum likelihood 
estimation (MLE) method which identifies parameters that maximizes the joint likelihood 
function (equation 4.5). 
 
4.2.2 Simulation study 
 
We conduct a simulation study to test the impact of violations of the uniformity 
assumption and the relative accuracy of methods for interval censored data. We simulate 
50 and 100 observations, each containing observed intervals ( , )a aL R and ( , )b bL R . We 
simulate true symptom onset time points A and B, determined by the true underlying 
serial interval distributions. Based on the limited estimates for the SI of TB [96],  we use 
a gamma distribution with a mean of 500 days (1.4 years) and a median of about 400 
days (1.1 years) (shape=2, rate=0.004)) for the underlying serial interval distribution. In 
reality, time points A and B are often not observed and are approximated by ( , )a aL R  and 
( , )b bL R instead. For ( , )a aL R , we use a beta distribution to allow the true unobserved 
time point A (Figure 4.2) to be skewed toward either the lower bound or the upper bound. 
For example, in the case where time point A is “right skewed” such that it is closer to the 
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upper bound 
aR , we first determine time point A ( )at  and B ( )bt  by drawing a serial 
interval from the gamma distribution. Next, we determine the length of interval ( , )a aL R ,  
a , by drawing from a uniform (14, max length) distribution. Here, we use 14 days as 
the lower bound of the uniform distribution from which we draw the interval length. For 
the upper bound (max length) of this uniform distribution, we consider 100, 200 and 300 
days as they have been reported to be reasonable maximum time of delay of diagnosis for 
TB [114]. Once the length of ( , )a aL R is determined, we draw a number, p, from a beta (5, 
1) (mean 0.83, median 0.87). Then we create interval censored data ( , )a aL R  where 
*a a aL t p    and (1 )*a a aR t p    . Since p is drawn from a beta with more density 
toward higher probabilities, p is likely closer to 1, making the interval ( , )a aL R  more 
likely to be “right skewed”— time point A is more likely closer to upper bound 
aR . A 
similar strategy is used for generating “left skewed” intervals for time point A using a 
beta (1, 5) distribution to draw p. We also consider the case where there is no skewness 
for time point A. For the interval ( , )b bL R , a beta (1, 1) distribution is used to draw p to 
not allow skewness in this interval. 
 
For interval ( , )b bL R , we follow the assumption in Reich [92] that the length of this 
interval is smaller than the length of ( , )a aL R . This assumption is reasonable for TB 
studies since household contacts are followed more closely in a prospective design which 
is likely to result in shorter delay of diagnosis and therefore shorter intervals. For each 
scenario, we run 1000 simulations. 
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We estimate the serial interval using seven methods:  
 
1. Doubly interval censoring method by Reich [92] which uses the likelihood 
function in (4.2) with weight function as shown in Figure 4.2; assumes uniformity 
on the interval ( , )a aL R ; denote this by “Doubly”. 
2. Reduced interval censoring by Reich [92] which uses the likelihood function in 
(4.2) with weight function as shown in Figure 4.4; assumes uniformity on the 
interval ( , )a aL R ; denote this by “Reduced”. 
3. The approximation method in (equation 4.4); uses a gamma distribution for ( )h a
without assigning weights on ( , )a aL R  ; denote this by “Rie”.  
4. The approximation method in (equation 4.4); uses a gamma distribution for ( )h a
with (30%, 70%) weighting; denote this by “Rie30”. 
5. The approximation method in (equation 4.4); uses a gamma distribution for ( )h a  
with (10%, 90%) weighting; denote this by “Rie10”. 
6. The approximation method in (equation 4.4); uses a gamma distribution for ( )h a
with (30%, 70%) split on the intervals and grouping on the less important part of 
the intervals; denote this by “Rie30_lp”. 
7. The approximation method in (equation 4.4); uses a gamma distribution for ( )h a
with (10%, 90%) split on the intervals and grouping on the less important part of 
the intervals; denote this by “Rie10_lp”. 
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8. The “mid point” approach [113] which uses the average of intervals ( , )a aL R and 
( , )b bL R as surrogates for time points A and B; denote this by “Mid”. 
9. The “no adjustment approach” which uses 
aR  and bR as surrogates for time points 
A and B. This is a common approach as 
aR and bR are diagnosis dates for TB 
disease; denote this by “Diag”. 
 
We also consider method 4) and method 5) when the weights are assigned to the opposite 
direction of the underlying skewness, and denote these two methods by “Inc_rie30”, and 
“Inc_rie10”. This means that, for instance, when the unobserved time point A is likely 
closer to the upper bound of its interval, we incorrectly assign weight by assigning more 
weights to the lower bound of the interval. Similarly for methods 6) and 7), we consider 
the scenarios when the grouping method based on a (30%, 70%) or a (10%, 90%) split is 
inconsistent with the underlying skewness of the intervals. For example, if we split the 
interval into 30% and 70%, incorrect grouping happens when we group the upper 70% 
for “left skewed” intervals. We denote this scenario by “Inc_rie30_lp”. Similarly, we 
denote the incorrect grouping scenario based on a (10%, 90%) split by “Inc_rie10_lp”. 
 
To evaluate the performance of the different approaches for estimation, we evaluate the 
bias of each estimator as well as the Mean Squared Error (MSE). More details on the 
simulations are in the appendix, including specific simulation scenarios considered. 
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4.2.3 Tuberculosis datasets 
 
Using the same data from Victoria Brazil [88] as described in Chapter 3, we apply the 
methods in section 4.2.2 on this dataset which includes 160 index cases who were 
enrolled and had active TB disease. A total of 958 individuals were living in the same 
households as these index cases. Of the 958 household contacts, 47 developed active TB 
disease during follow-up, ranging between 2 to 6 years.  
 
 
4.3 Results 
 
4.3.1 Simulation results 
 
Using the approximation methods (“Rie30”, “Rie10”) with weighting and approximation 
methods with grouping (“Rie30_lp” and “Rie10_lp”) achieves higher efficiency by 
reducing the computing time by approximately 50% compared to the method without 
weighting (“Rie”).  
 
In addition to higher efficiency from using the approximation methods with weighting, 
we also obtain better serial interval estimates (lower bias, lower mean squared error) 
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when we assign weights that are consistent with the underlying “skewness”. For example, 
when the unobserved symptom onset time point A is closer to the lower bound, correctly 
assigning weights means assigning more weights to the lower third of the interval 
( , )a aL R where time point A falls.  
  
When the unobserved time point A tends to be “left skewed”, meaning it is likely closer 
to the lower bound of the interval ( , )a aL R , using a uniform distribution for time point A 
results in underestimation of the mean serial interval. This underestimation can be 
corrected by using a gamma distribution for time point A in the approximation method 
(equation 4.4) without assigning weights (method “Rie”), as the skewness of the gamma 
distribution itself allows the correction. The underestimation is further corrected by the 
approximation with weights that are consistent with the true underlying skewness of the 
interval ( , )a aL R , and the benefit of the weights is more apparent as the maximum length 
of the interval ( , )a aL R increases from 100 days to 300 days (Figure 4.6, Table A.4.1). 
 
A similar pattern is observed when the time point A tends to be “right skewed”, although 
the benefit of using the approximation method with weights is smaller due to the 
skewness of the gamma distribution itself which is used for the time point A. The 
overestimation of the serial interval is corrected by the approximation with weights that 
are consistent with the true underlying skewness of the interval, and the degree of 
correction is more apparent as the maximum length of the interval ( , )a aL R  increases 
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from 100 days to 300 days (Figure 4.6, Table A.4.1). 
 
The mid point imputation method performs relatively poorly as the maximum length of 
the interval ( , )a aL R  is relatively large compared to the mean serial interval (100-300 
days compared to 500 days), which is consistent with what is reported in [113]. The 
“diag” approach which uses the time from 
aR to bR  performs poorly except for when the 
interval ( , )a aL R tends to be right skewed.  
 
In general, the two methods, “Doubly” and “Reduced” by Reich et al. [92] perform 
similarly, which is consistent with what is reported in their paper. The approximation 
method with the two different ways of weighting, “Rie30” and “Rie10” also perform 
similarly. As the interval length for ( , )a aL R increases from 100 to 300, “Rie10” 
performed somewhat better in terms of producing lower MSE as the (10%, 90%) 
weighting aligns better with the underlying skewness of the intervals than the (30%, 
70%) weighting.  
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Figure 4. 6: Bias of mean serial interval for right skewed intervals, maximum interval 
length 100 days, 200 days and 300 days, sample size is 50. 
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Figure 4. 7: Bias of mean serial interval for left skewed intervals, maximum interval 
length 100 days, 200 days and 300 days, sample size is 50. 
Footnotes for Figure 4.6 and Figure 4.7: 1) “Doubly” is the double interval censoring 
from Reich [92]; 2) “Reduced” is the reduced interval censoring from Reich [92]; 3) 
“Rie” is the approximation method without weighting; 4) “Rie30” is the approximation 
method with correct (30%, 70%) weighting; 5) “Rie10” is the approximation method 
with correct (10%, 90%) weighting; 6) “Mid” is the mid point imputation; 7) “Diag” is 
the diagnosis to diagnosis (upper bound to upper bound) approach; 8) “Inc_rie30” is 
using incorrect (30%, 70%) weighting in the approximation method; 9) “Inc_rie10” is 
using incorrect (10%, 90%) weighting in the approximation method;  10) “Rie30_lp” is 
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the approximation method with correct grouping based on a (30%, 70%) split on the 
intervals; 11) “Rie10_lp” is the approximation method with correct grouping based on a 
(10%, 90%) split on the intervals; 12) “Inc_rie30_lp” is the approximation method with 
incorrect grouping based on a (30%, 70%) split on the intervals; 13) “Inc_rie10_lp” is the 
approximation method with incorrect grouping based on a (10%, 90%) split on the 
intervals. 
 
Incorrect assignment of weights happens when the assigned weights are in the opposite 
direction of the skewness in the intervals. For example, when the unobserved symptom 
onset time point A is closer to the lower bound, incorrectly assigning weights means 
assigning weights to the upper third of the interval ( , )a aL R . For methods “Rie30” and 
“Rie10”, incorrect assignment of weights results in higher bias in the same direction 
compared to other approaches, including the ones that use a uniform distribution for 
interval ( , )a aL R  (Figures 4.4 and 4.5). The MSE is also the highest when incorrect 
weights are used in these methods (Table A.4.1).  
 
Although the approximation methods with grouping, “Rie30_lp” and “Rie10_lp”, reduce 
the computing time by about 50%, they only produce slightly better serial interval 
estimates (lower bias, mean squared error) in certain scenarios. In most cases, these two 
methods perform similarly as the approximation method “Rie” which does not use any 
weighting (Table A.4.1). However, these two methods do not perform nearly as poorly as 
“Rie30” and “Rie10” when the grouping is inconsistent with the underlying skewness of 
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the intervals (Table A.4.1). 
 
Increasing the sample size from 50 to 100 does not change the above results.  
 
4.3.2 Real data results 
 
For the Brazil data, we set up the interval censored data as follows: for the index case (the 
first interval), we used the diagnosis dates as the upper bound and subtract from the 
diagnosis dates the number of weeks that the index cases had started to feel sick to 
determine the lower bound. Therefore, the length of the interval for the index cases, a , 
is equal to the number of weeks that they had started to feel sick. For the household 
contacts (the second interval), we used the diagnosis dates as the upper bound; for the 
lower bound for each subject, we drew an interval of length 
b  such that b a   and 
then subtracted the length from the upper bound to compute the lower bound. We applied 
all seven estimation methods on the Brazil data [88]. The estimated mean serial interval 
and 95% bootstrap confidence intervals are shown in Table 4.1. For this data, it is 
reasonable to assume that index cases were sick for a considerable amount of time before 
they were diagnosed with TB. Therefore, when using the approximation method with 
weights, “rie30” and “rie10”, more weights were given to the lower bound of the 
intervals for the index cases. As expected, the two methods from Reich et al. [92] yield 
similar results (Table 4.1) when applied to the Brazil data with the serial interval 
estimated at around 1.81 days (95% CI: 1.37-2.29). The approximation method with 
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weights, “rie30” and “rie10” yield larger estimated serial intervals at around 1.85 years 
(95% CI: 1.41-2.33). This is consistent with the simulation results where “right 
skewness” tends to result in underestimation of the serial interval if methods such as 
“doubly”, “reduced” are used with the uniformity assumption. The “diag” approach 
yields a lower estimated serial interval at 1.5 years (95% CI: 1.07-2.11) while the “mid” 
approach yields a similar estimated serial interval as “doubly” and “reduced”. The 
approximation methods with grouping, “Rie30_lp” and “Rie10_lp” yield similar results 
as the approximation method without any weighting (method “Rie”), which is consistent 
with the simulation results.  
 
 
Table 4. 1: Estimated mean serial interval and 95% confidence interval.  
 
Method Estimated mean SI in years (95% 
confidence interval) 
Doubly 1.81 (1.37-2.29) 
Reduced 1.81 (1.36-2.29) 
Rie, gamma 1.81 (1.37-2.30) 
Rie30 1.85 (1.41-2.33) 
Rie10 1.85 (1.41-2.34) 
Mid  1.82 (1.38-2.29) 
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Diag 1.72 (1.27-2.20) 
Rie30_lp 1.81 (1.37-2.30) 
Rie10_lp 1.82 (1.38-2.30) 
 
 
Footnote: doubly: the doubly interval censoring method by Reich [92]; Reduced: the 
reduced interval censoring method by Reich [92]; Rie: the approximation method without 
using weights; Rie30: the approximation method using (30%, 70%) weights; Rie10: 
approximation method using (10%, 90%) weights; Mid: the mid point imputation 
method; Diag: the method using diagnosis dates as the surrogates for symptom onset time 
for the infector and the infected person; Rie30_lp: the approximation method with (30%, 
70%) split on the intervals and grouping on the lower part of the intervals; Rie10_lp: the 
approximation method with (10%, 90%) split on the intervals and grouping on the lower 
part of the intervals. 
 
4.4 Discussion 
 
The slow progression of TB and nonspecific symptomology makes it challenging to 
observe the symptom onset of the infector (time point A) and the infected person (time 
point B), which are needed to calculate the serial interval. In reality, both time points 
often are coarsely measured and fall in their own intervals: ( , )a aL R and ( , )b bL R . In TB 
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studies, it is common to use 
aR and bR , which are disease diagnosis dates as surrogates 
for the unobserved time point A and B. In other diseases, the mid point imputation has 
also been widely used [113]. Reich et al. [92] derived a likelihood function that uses a 
double integral to allow the contribution to the likelihood from all possible values in 
( , )a aL R and ( , )b bL R  but simplifies the problem by assuming that A is uniformly 
distributed, an assumption that is unlikely to hold in TB. In this paper, we relax the 
assumption of using a uniform distribution for time point A in [92] by using the Riemann 
sum to approximate the likelihood function. We first show that computation efficiency is 
achieved (reducing the computing time by about 50%) with assigning fewer weights to 
the side of the intervals that we think has less important information. Next, we show that 
the serial interval estimate is biased when there is skewness in the interval ( , )a aL R . This 
bias can be decreased by assigning weights in the approximation method and allowing for 
alternative distributions to the uniform. We show that when the specified weights are in 
accordance with the underlying skewness of the intervals, our approach consistently 
produces lower bias and MSE than existing approaches. However, our approach performs 
poorly when the specified weights are in the opposite direction of the underlying interval 
skewness, producing higher bias and MSE as compared to the other approaches. The 
approximation approach with grouping provides higher efficiency in computing, but does 
not provide more accuracy in estimating the serial interval. However, this approach is far 
less sensitive to incorrect specification of which side of the interval is more important 
compared to the approximation approach with weighting. 
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When applied to the empirical Brazil dataset, the nine methods we considered yield 
results consistent with the simulation results. The method that uses the diagnosis dates as 
surrogates for symptom onset time (“diag”) yields a shorter serial interval. The two 
methods by Reich [92] yield similar results, while the approximation method we propose 
yields a larger serial interval, correcting the potential underestimation of the serial 
interval. Compared to the estimated serial intervals in Chapter 3 (Table A.3.2) using the 
cure model approach on the same dataset, the estimates in this chapter are smaller 
(around 1.8 years vs. 2.1 years). This is expected as the cure model approach takes into 
account the longer serial intervals that are not observed. 
 
Our approach is subject to a few limitations. As in [92], we use the same assumption that 
time point A is independent of the serial interval, which may not be true. We also assume 
that the length of the second interval ( , )b bL R is smaller than the interval ( , )a aL R . This is 
a reasonable assumption in TB studies as the household contacts are followed more 
closely than the index cases and likely to seek care more quickly than their infectors. 
However one can imagine violations of this assumption. 
 
As mentioned previously, the serial interval is an important quantity for describing the 
transmission dynamics of infectious diseases. Although the approaches we considered are 
relevant to TB, they can be used to estimate the serial interval for other infectious 
diseases as well, as we have shown that more accurate estimates can be obtained by 
relaxing the uniformity assumption on the intervals. In this dissertation, we considered 
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using a cure model to address the right censoring issue under the assumption that the 
diagnosis time is a good surrogate for symptom onset time; we then considered relaxing 
the assumption in Reich [92] by using an approximation method with weighting or 
grouping to address the interval censoring issue, assuming that all the serial intervals 
were observed. In the future, we can potentially combine these two parts by deriving a 
method that addresses both the right censoring and the interval censoring issue 
simultaneously. 
 
 
4.5 Appendix 
 
4.5.1 Simulation details 
 
The true underlying distribution is a gamma (2, 0.005) with a mean of 500 days and a 
median of 400 days. The two sample sizes being considered are 50 and 100. For sample 
size 50, a random number is drawn from a poisson (50) distribution to determine the 
sample size in each of the 1000 simulations, and similarly for sample size 100. For 
interval ( , )a aL R  in Figure 4.2, a beta (1,5) is used to generate “left skewed” intervals 
where time point A is likely to be closer to the lower bound aL ; a beta (5,1) is used to 
generate “right skewed” intervals where time point A is likely to be closer to the upper 
bound 
aR ; a beta (1,1) is used for where there is likely no skewness in the intervals. 
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We consider the following methods to estimate the serial interval: 
 
1. Doubly interval censoring method by Reich [92] which uses the likelihood function in 
(4.2) with weight function as shown in Figure 4.2; assumes uniformity on the interval 
( , )a aL R ; denote this by “Doubly”. 
2. Reduced interval censoring by Reich [92] which uses the likelihood function in (4.2) 
with weight function as shown in Figure 4.4; assumes uniformity on the interval ( , )a aL R ; 
denote this by “Reduced”. 
3. The approximation method in (equation 4.4); uses a gamma distribution for ( )h a
without assigning weights on ( , )a aL R  ; denote this by “Rie”.  
4. The approximation method in (equation 4.4); uses a gamma distribution for ( )h a with 
(30%, 70%) weighting; denote this by “Rie30”. 
5. The approximation method in (equation 4.4); uses a gamma distribution for ( )h a  with 
(10%, 90%) weighting; denote this by “Rie10”. 
6. The approximation method in (equation 4.4); uses a gamma distribution for ( )h a with 
(30%, 70%) split on the intervals and grouping on the less important part of the intervals; 
denote this by “Rie30_lp”. 
7. The approximation method in (equation 4.4); uses a gamma distribution for ( )h a with 
(10%, 90%) split on the intervals and grouping on the less important part of the intervals; 
denote this by “Rie10_lp”. 
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8. The “mid point” approach [113] which uses the average of intervals ( , )a aL R and 
( , )b bL R as surrogates for time points A and B; denote this by “Mid”. 
9. The “no adjustment approach” which uses 
aR  and bR as surrogates for time points A 
and B. This is a common approach as 
aR and bR are diagnosis dates for TB disease; 
denote this by “Diag”. 
 
We also consider method 4) and method 5) when the weights are assigned to the opposite 
direction of the underlying skewness, and denote these two methods by “Inc_rie30”, and 
“Inc_rie10”. Similarly for methods 6) and 7), we consider the scenarios when the 
grouping method based on a (30%, 70%) or a (10%, 90%) split is inconsistent with the 
underlying skewness, and denote these two methods by “Inc_rie30_lp” and 
“Inc_rie10_lp”. 
 
To evaluate the performance of the different approaches for estimation we evaluate the 
bias of each estimator as well as the Mean Squared Error (MSE). For the bias, we first 
use boxplots to examine the estimated mean serial intervals and then compute the bias m 
in each estimator in the 1000 simulations as: 
1000
1
1
ˆ*
1000 i
m  

  , where ˆ is the 
estimated mean, and  is the true mean serial interval. The MSE is calculated as 
2ˆ( )
ˆ( ) ,  1,2,...,1000
j
j j
j
MSE j
n
 


   where   is the true mean of the serial interval and 
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jn  is the sample size in the jth simulation run. This is calculated for each of the 1000 
simulation runs in each scenario, and will be summarized as a distribution with median, 
1st and 3rd quantile. 
 
 
4.5.2 Simulation results 
 
First, we use boxplots to examine the estimated mean serial interval based on 1000 
simulations from each method. Figure A.4.1a demonstrates the scenarios where the 
underlying intervals are “left skewed”: the unobserved time point A is likely closer to the 
lower bound of the intervals; Figure A.4.1b demonstrates the scenarios where the 
underlying intervals are “right skewed”: the unobserved time point A is likely closer to 
the upper bound of the intervals; Figure A.4.1c demonstrates the scenarios where the 
underlying intervals are “not skewed”: the unobserved time point A is closer to neither 
the lower or upper bounds of the intervals on average. 
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Figure A.4.1 a: estimated mean serial interval based on 1000 simulations from each 
method when underlying intervals are “right skewed”. 
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Figure A.4.1 b: estimated mean serial interval based on 1000 simulations from each 
method when underlying intervals are “left skewed”. 
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Figure A.4.1 c: estimated mean serial interval based on 1000 simulations from each 
method when underlying intervals are “neither right skewed nor left skewed”. 
 
Footnotes for Figure A.4.1: (a) The double interval censoring from Reich [92]; (b) The 
reduced interval censoring from Reich [92]; (c) The approximation method without 
weighting; (d) The approximation method with correct (30%, 70%) weighting; (e) The 
approximation method with correct (10%, 90%) weighting; (f) The mid point imputation; 
(g) The diagnosis to diagnosis (upper bound to upper bound) approach; (h) The incorrect 
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(30%, 70%) weighting in the approximation method; (i) The incorrect (10%, 90%) 
weighting in the approximation method; (j) The approximation method with correct 
grouping based on a (30%, 70%) split on the intervals; (k) The approximation method 
with correct grouping based on a (10%, 90%) split on the intervals; (l) The approximation 
method with incorrect grouping based on a (30%, 70%) split on the intervals; (m) The 
approximation method with incorrect grouping based on a (10%, 90%) split on the 
intervals. 
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Table A.4. 1: Bias and Mean squared error (MSE) for maximum interval length of 100, 
200, 300 days 
 
A.4.1.1a: Bias, sample size=50  
Max interval 
Length 
100 days 200 days 300 days 
 Bias, median, 
1st and 3rd 
quartile 
Bias, median, 
1st and 3rd 
quartile 
Bias, median, 1st 
and 3rd quartile 
Right skewed intervals 
Doubly 13.1 (-19.6, 
49.6) 
36.2 (-0.3, 70.2) 50.4 (15.3, 84.4) 
Reduced 12.9 (-19.8, 
49.4) 
35.3 (-1.1, 69.5) 48.6 (12.9, 82.3) 
Rie 13.4 (-19.7, 
49.5) 
34.6 (-1.9, 68.9) 44.5 (10.0, 79.6) 
Rie30 5.9 (-26.9, 42.3) 21.1 (-14.7, 
56.0) 
26.3 (-7.9, 60.9) 
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Rie10 6.6 (-26.4, 42.7) 21.7 (-13.9, 
56.2) 
26.3 (-7.6, 61.7) 
Rie30_lp 13.2 (-19.8, 
49.3) 
34.4 (-2.3, 68.7) 43.5 (8.7, 78.8) 
Rie10_lp 14.0 (-19.0, 
50.1) 
35.9 (-1.0, 70.1) 45.4 (10.8, 80.4) 
Mid 13.1 (-19.4, 
49.7) 
37.0 (0.4, 70.9) 52.5 (18.3, 86.8) 
Diag 2.2 (-29.9, 38.9) 12.5 (-23.8, 
47.8) 
15.1 (-19.1, 49.9) 
Incorrect Rie30 19.6 (-12.8, 
55.7) 
46.9 (10.0, 
80.8) 
60.0 (25.8, 95.0) 
Incorrect Rie10 20.3 (-12.0, 
56.4) 
47.7 (11.0, 
81.5) 
60.6 (25.6, 94.9) 
Incorrect Rie30_lp 12.9 (-20.1, 
48.9) 
33.8 (-2.9, 68.0) 42.6 (8.0, 77.9) 
Incorrect Rie10_lp 14.2 (-19.0, 
50.1) 
36.0 (-0.9, 70.2) 45.7 (11.1, 80.8) 
Left skewed intervals   
Doubly -19.8 (-51.4, 
14.4) 
-31.1 (-64.8, 
1.8) 
-44.5 (-75.6, -8.9) 
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Reduced -19.9 (-51.5, 
14.4) 
-31.9 (-65.9, 
1.0) 
-46.8 (-79.4, -11.4) 
Rie -18.7 (-50, 
15.4) 
-26.8 (-60.6, 
5.5) 
-38.1 (-70.0, -1.1) 
Rie30 -11.7 (-42.9, 
21.8) 
-13.8 (-48.8, 
18.0) 
-19.7 (-51.2, 16.3) 
Rie10 -10.9 (-42.0, 
22.7) 
-12.0 (-46.6, 
19.5) 
-17.4 (-49.4, 18.6) 
Rie30_lp -19.1 (-50.6, 
15.0) 
-27.6 (-61.3, 
4.7) 
-38.9 (-70.4, -1.9) 
Rie10_lp -17.9 (-49.3, 
16.1) 
-25.5 (-59.4, 
6.7) 
-36.2 (-67.6, 0.8) 
Mid -19.7 (-51.6, 
14.5) 
-30.0 (-63.4, 
2.7) 
-42.2 (-73.2, -6.4) 
Diag -30.9 (-62.8, 
3.3) 
-55.1 (-89.4, -
23.5) 
-84.4 (-117.6, -
47.4) 
Incorrect  
Rie30 
-26.2 (-57.7, 
8.4) 
-40.8 (-74.2, -
7.7) 
-57.7 (-91.0, -21.5) 
Incorrect Rie10 -25.4 (-56.7, 
9.2) 
-38.6 (-72.5, -
5.8) 
-54.1 (-87.3, -17.1) 
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Incorrect_Rie30_lp -18.8 (-50.2, 
15.3) 
-27.2 (-60.8, 
5.3) 
-38.2 (-69.7, -1.2) 
Incorrect_Rie10_lp -17.9 (-49.3, 
16.1) 
-25.4 (-59.3, 
6.8) 
-36.0 (-67.5, 1.0) 
Uniform intervals   
Doubly -0.9 (-34.4, 
30.5) 
1.2 (-30.7, 33.5) 3.6 (-28.0, 38.7) 
Reduced -1.1 (-34.6, 
30.4) 
0.2 (-31.8, 32.5) 1.7 (-30.4, 36.7) 
Rie, gamma -0.4 (-33.8, 
31.1) 
2.9 (-29.7, 33.8) 4.7 (-25.8, 38.6) 
Expo 1.0 (-32.2, 32.6) 7.1 (-24.9, 39.6) 14.2 (-17.7, 48.8) 
Rie30 6.3 (-27.0, 37.9) 14.9 (-18.1, 
45.8) 
21.0 (-9.4, 55.7) 
Rie10 7.1 (-26.3, 38.7) 16.3 (-17.0, 
47.2) 
22.0 (-8.2, 56.6) 
Rie30_lp -0.7 (-34.2, 
30.7) 
2.1 (-30.6, 33.0) 3.1 (-26.7, 37.5) 
Rie10_lp 0.3 (-33.1, 31.8) 4.1 (-28.3, 25.1) 6.0 (-24.3, 40.2) 
Mid -0.9 (-34.2, 
30.5) 
1.8 (-29.6, 34.0) 5.9 (-25.5, 40.5) 
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Diag -11.0 (-44.6, 
20.4) 
-22.2 (-54.7, 
9.9) 
-33.0 (-64.3, 0.70) 
 
A.4.1.1b: MSE, sample size=50  
Max 
interval 
Length 
100 days 200 days 300 days 
 MSE, median, 1st 
and 3rd quartile 
MSE, median, 1st 
and 3rd quartile 
MSE, median, 1st 
and 3rd quartile 
Right skewed intervals 
Doubly 23.1 (5.1, 72.1) 37.6 (8.2, 103.2) 54.8 (13.5, 148.0) 
Reduced 22.9 (5.1, 72.1) 37.0 (8.4, 101.0) 52.3 (13.1, 143.1) 
Rie, gam  23.2 (5.1, 73.0) 36.8 (7.9, 101.2) 47.3 (11.3, 131.7) 
Expo 24.0 (5.2, 75.5) 45.0 (9.1, 120.0) 74.5 (19.1, 186.2) 
Rie30 23.0 (5.3, 66.1) 27.3 (6.8, 83.2) 31.8 (7.1, 90.1) 
Rie10 22.7 (5.3, 67.1) 27.6 (7.0, 84.2) 32.6 (7.3, 91.3) 
Rie30_lp 23.1 (5.0, 73.0) 36.8 (8.0, 100.6) 45.7 (10.9, 127.4) 
Rie10_lp 23.5 (5.1, 74.1) 37.4 (8.3, 104.2) 49.0 (11.5, 133.2) 
Mid 23.4 (5.0, 72.9) 38.8 (8.4, 106.0) 57.7 (14.6, 153.5) 
Diag 23.1 (5.0, 65.7) 25.4 (6.0, 73.4) 24.6 (5.6, 77.9) 
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Incorrect 
Rie30 
23.9 (5.1, 81.5) 49.3 (11.0, 132.8) 74.6 (19.2, 185.1) 
Incorrect 
Rie10 
23.8 (5.2, 83.5) 51.1 (10.9, 135.4) 74.9 (19.2, 183.8) 
Incorrect 
Rie30_lp 
22.7 (5.1, 72.8) 36.0 (7.9, 98.7) 44.7 (10.3, 124.3) 
Incorrect 
Rie10_lp 
23.5 (5.1, 74.1) 37.7 (8.2, 104.7) 49.4 (11.5, 134.5) 
Left skewed intervals 
Doubly 23.5 (6.3, 78.3) 34.3 (8.0, 98.2) 50.7 (11.6, 120.4) 
Reduced 23.7 (6.3, 78.1) 35.8 (8.4, 100.0) 56.0 (13.3, 130.3) 
Rie gam 23.0 (6.1, 78.1) 29.7 (6.1, 88.7) 41.2 (9.9, 106.7) 
Expo 22.3 (5.8, 76.4) 29.0 (5.7, 86.4) 37.1 (9.1-98.6) 
Rie30 20.3 (4.9, 72.4) 24.0 (5.3, 72.9) 29.1 (6.7, 81.2) 
Rie10 20.6 (4.8, 73.5) 23.6 (5.0, 69.7) 29.0 (6.5, 80.5) 
Rie30_lp 23.3 (6.1, 77.4) 29.9 (6.5, 90.7) 42.4 (10.2, 108.3) 
Rie10_lp 22.7 (6.0, 76.8) 28.8 (5.8, 87.5) 38.7 (9.9, 103.3) 
Mid 23.4 (6.2, 77.9) 32.1 (7.3, 96.7) 46.3 (11.2, 112.8) 
Diag 30.3 (7.9, 88.6) 68.6 (19.7, 161.7) 148.3 (48.3, 277.0) 
Incorrect 
Rie30 
28.2 (6.7, 83.5) 45.5 (11.4, 121.5) 70.8 (19.5, 162.9) 
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Incorrect 
Rie10 
27.3 (6.4, 82.9) 43.0 (10.5, 116.3) 66.1 (16.9, 150.7) 
Incorrect 
Rie30_lp 
23.0 (6.1, 78.1) 29.8 (6.2, 89.2) 41.4 (9.9, 106.6) 
Incorrect 
Rie10_lp 
22.7 (6.0, 76.7) 28.8 (5.8, 87.3) 38.3 (9.9, 102.8) 
Uniform intervals 
Doubly 21.2 (4.8, 66.9) 20.5 (4.1, 64.8) 21.1 (4.5, 64.6) 
Reduced 21.3 (4.7, 66.7) 20.8 (3.9, 63.8) 21.6 (4.6, 66.1) 
Rie 21.5 (4.8, 67.0) 21.0 (4.5, 65.3) 20.4 (4.6,67.1) 
Rie30 22.6 (4.7, 67.1) 22.5 (5.1, 69.8) 25.3 (5.3, 79.0) 
Rie10 23.1 (4.7, 68.4) 22.6 (5.2, 71.2) 24.4 (5.7, 80.4) 
Rie30_lp 21.3 (4.8, 67.2) 20.7 (4.5, 65.6) 20.1 (4.7, 67.4) 
Rie10_lp 21.1 (4.8, 67.7) 22.1 (4.8, 65.2) 20.7 (4.6, 67.8) 
Mid 21.3 (4.7, 66.9) 20.9 (4.4, 64.9) 20.4 (4.5, 63.6) 
Diag 22.5 (5.0, 68.4) 26.2 (5.9, 79.5) 38.6 (8.8, 98.1) 
 
A.4.1.2a: Bias, sample size=100 
Max interval 
Length 
100 days 200 days 300 days 
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 Bias, median, 1st 
and 3rd quartile 
Bias, median, 
1st and 3rd 
quartile 
Bias, median, 
1st and 3rd 
quartile 
Right skewed intervals   
Doubly 19.4 (-3.2, 44.2) 34.9 (10.4, 
57.6) 
47.4 (24.9, 
71.2) 
Reduced 19.4 (-3.3, 44.0) 34.0 (9.9, 56.9) 45.1 (22.5, 
69.0) 
Rie 20.0 (-2.9, 44.4) 33.6 (9.1, 56.0) 42.2 (19.9, 
65.5) 
Rie30 12.5 (-10.1, 37.1) 20.1 (-4.4, 42.4) 22.7 (1.2, 46.9) 
Rie10 13.2 (-9.5, 37.8) 20.0 (-3.4, 43.2) 23.3 (1.6, 46.8) 
Rie30_lp 19.9 (-3.0, 44.3) 33.4 (8.8, 55.7) 40.4 (18.4, 
63.3) 
Rie10_lp 20.7 (-2.2, 45.1) 34.9 (10.3, 
57.2) 
42.3 (20.3, 
65.5) 
Mid 19.6 (-2.9, 44.4) 36.0 (11.6, 
58.3) 
49.7 (27.4, 
73.3) 
Diag 8.8 (-13.3, 33.4) 11.3 (-12.2, 
34.4) 
11.6 (-10.3, 
35.1) 
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Incorrect Rie30 26.5 (3.8, 50.9) 45.2 (21.3, 
68.4) 
57.4 (35.4, 
80.5) 
Incorrect Rie10 27.3 (4.6, 51.7) 45.8 (22.2, 
69.0) 
57.3 (35.3, 
81.0) 
Incorrect_Rie30_lp 19.6 (-3.4, 44.0) 32.8 (8.3, 55.2) 39.6 (17.7, 
62.7) 
Incorrect_Rie10_lp 20.7 (-2.2, 45.2) 34.9 (10.4, 
57.4) 
42.6 (20.6, 
65.9) 
Left skewed intervals   
Doubly -17.9 (-43.1, 7.3) -32.5 (-55.2, -
7.5) 
-44.7 (-67.1, -
19.3) 
Reduced -18.0 (-43.3, 7.2) -33.6 (-56.4, -
8.5) 
-47.3 (-70.0, -
21.7) 
Rie -16.9 (-42.1, 7.9) -28.5 (-51.4, -
4.3) 
-36.7 (-60.8, -
11.8) 
Rie30 -9.9 (-35.4, 14.6) -15.7 (-38.9, 
8.1) 
-18.8 (-42.6, 
6.5) 
Rie10 -9.0 (-34.5, 15.4) -14.0 (-37.4, 
9.8) 
-16.4 (-40.6, 
9.4) 
Rie30_lp -17.3 (-42.5, 7.4) -29.1 (-52.1, -
5.0) 
-37.5 (-61.7, -
12.3) 
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Rie10_lp -16.1 (-41.4, 8.5) -27.2 (-50.2, -
3.1) 
-34.9 (-59.0, -
9.6) 
Mid -17.9 (-42.9, 7.4) -31.4 (-54.2, -
6.7) 
-41.9 (-64.7, -
17.4) 
Diag -29.4 (-53.9, -
3.8) 
-56.9 (-79.6, -
31.9) 
-85.1 (-107.8, -
58.2) 
Incorrect Rie30 -24.4 (-49.5, 0.6) -42.5 (-65.2, -
18.2) 
-57.4 (-81.2, -
31.2) 
Incorrect Rie10 -23.4 (-48.6, 1.3) -40.2 (-63.1, -
16.0) 
-53.0 (-77.2, -
27.3) 
Incorrect_Rie30_lp -17.0 (-42.2, 7.7) -28.7 (-51.6, -
4.4) 
-37.0 (-61.0, -
11.5) 
Incorrect_Rie10_lp -16.1 (-41.4, 8.6) -27.1 (-50.1, -
2.9) 
-34.6 (-58.7, -
9.4) 
Uniform intervals   
Doubly -1.3 (-24.8, 22.2) -1.0 (-24.2, 
23.7) 
3.8 (-20.9, 
27.0) 
Reduced -1.4 (-25.0, 22.1) -1.9 (-25.0, 
23.2) 
1.4 (-22.9, 
25.4) 
Rie -0.6 (-24.5, 22.8) 0.1 (-23.1, 24.6) 4.7 (-19.7, 
28.5) 
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Rie30 6.1 (-17.3, 29.6) 12.2 (-11.2, 
36.1) 
21.0 (-2.8, 
45.6) 
Rie10 6.9 (-16.6, 30.4) 13.4 (-9.9, 37.4) 22.5 (-1.2, 
46.9) 
Rie30_lp -1.0 (-24.9, 22.4) -0.7 (-24.0, 
23.9) 
3.5 (-21.3, 
26.8) 
Rie10_lp 0.1 (-23.7, 23.5) 1.5 (-21.8, 25.7) 6.2 (-18.5, 
29.7) 
Mid -1.3 (-24.8, 22.4) -0.2 (-23.2, 
24.5) 
6.1 (-18.3, 
29.1) 
Diag -12.2 (-35.8, 
11.6) 
-25.2 (-48.2, 
0.5) 
-34.3 (-56.8, -
9.2) 
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A.4.1.2b: MSE, sample size=100  
Max interval 
Length 
100 days 200 days 300 days 
 MSE, median, 1st 
and 3rd quartile 
MSE, median, 1st 
and 3rd quartile 
MSE, median, 
1st and 3rd 
quartile 
Right skewed intervals 
Doubly 6.8 (1.4, 21.6) 13.6 (3.5, 33.9) 21.7 (6.5, 50.7) 
Reduced 6.8 (1.4, 21.5) 13.2 (3.4, 33.1) 19.9 (5.6, 47.6) 
Rie 6.9 (1.4, 21.5) 12.9 (3.2, 32.5) 17.9 (4.9, 43.5) 
Rie30 5.6 (1.2, 17.3) 7.8 (2.0, 21.7) 7.6 (1.6, 22.4) 
Rie10 5.7 (1.3, 17.6) 8.0 (2.0, 22.2) 7.8 (1.6, 23.2) 
Rie30_lp 6.9 (1.4, 21.3) 12.8 (3.1, 32.1) 16.2 (4.2, 40.6) 
Rie10_lp 6.8 (1.5, 22.0) 13.4 (3.4, 33.7) 17.9 (4.7, 43.3) 
Mid 6.8 (1.4, 21.6) 14.1 (3.7, 34.6) 23.8 (7.7, 52.8) 
Diag 5.3 (1.1, 16.8) 6.1 (1.4, 17.9) 5.8 (1.2, 17.0) 
Incorrect 
Rie30 
8.3 (2.0, 27.2) 20.7 (5.8, 46.9) 32.5 (12.2, 65.9) 
Incorrect 
Rie10 
8.7 (2.1, 27.8) 21.2 (6.1, 47.9) 32.3 (12.4, 65.4) 
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Incorrect 
Rie30_lp 
6.8 (1.4, 21.1) 12.3 (2.9, 31.5) 15.7 (4.0, 39.6) 
Incorrect 
Rie10_lp 
6.8 (1.5, 22.0) 13.6 (3.4, 33.8) 18.2 (4.9, 43.8) 
Left skewed intervals 
Doubly 7.7 (2.0, 22.4) 13.2 (3.0, 32.3) 20.9 (5.3, 45.2) 
Reduced 7.8 (2.0, 22.4) 13.7 (3.1, 33.5) 23.0 (6.2, 49.3) 
Rie 7.4 (1.8, 21.8) 11.2 (2.4, 28.3) 16.0 (3.9, 37.2) 
Rie30 7.1 (1.5, 19.4) 6.8 (1.7, 20.8) 8.4 (2.1, 22.1) 
Rie10 6.9 (1.5, 19.2) 6.7 (1.6, 20.2) 8.2 (1.9, 21.5) 
Rie30_lp 7.5 (1.9, 22.0) 11.4 (2.5, 29.1) 16.4 (4.1, 38.3) 
Rie10_lp 7.4 (1.7, 21.1) 10.7 (2.3, 27.9) 14.5 (3.3, 35.3) 
Mid 7.7 (2.0, 22.4) 12.6 (2.8, 31.7) 19.1 (5.0, 41.9) 
Diag 10.9 (2.6, 29.9) 32.4 (11.1, 63.3) 72.3 (34.0, 
115.6) 
Incorrect 
Rie30 
9.3 (2.4, 26.2) 19.0 (5.2, 43.7) 33.4 (10.7, 65.6) 
Incorrect 
Rie10 
8.9 (2.4, 25.5) 17.2 (4.5, 41.0) 29.0 (8.9, 60.1) 
Incorrect 
Rie30_lp 
7.4 (1.9, 21.8) 11.3 (2.5, 28.6) 15.9 (3.8, 37.5) 
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Incorrect 
Rie10_lp 
7.4 (1.7, 21.1) 10.7 (2.3, 27.7) 14.5 (3.3, 35.1) 
Uniform intervals 
Doubly 5.6 (1.4, 16.7) 5.7 (1.3, 15.6) 5.9 (1.1, 16.5) 
Reduced 5.5 (1.4, 16.6) 5.9 (1.3, 15.9) 5.8 (1.1, 16.2) 
Rie 5.6 (1.4, 16.5) 5.7 (1.3, 15.6) 5.7 (1.1, 16.6) 
Rie30 6.1 (1.4, 16.8) 5.8 (1.3, 17.5) 7.4 (1.9, 22.9) 
Rie10 6.2 (1.4, 16.6) 6.1 (1.3, 18.2) 7.6 (2.0, 24.0) 
Rie30_lp 5.6 (1.4, 16.6) 5.7 (1.3, 15.5) 5.8 (1.1, 16.3) 
Rie10_lp 5.6 (1.4, 16.6) 5.6 (1.2, 15.7) 5.8 (1.2, 16.8) 
Mid 5.6 (1.4, 16.7) 5.8 (1.3, 15.6) 5.7 (1.2, 16.8) 
Diag 6.5 (1.4, 18.8) 9.3 (2.3, 25.1) 13.7 (3.6, 34.0) 
 
Footnotes for Table A.4.1: 1) “Doubly” is double interval censoring from Reich [92]; 2) 
“Reduced” is reduced interval censoring from Reich [92]; 3) “Rie” is the approximation 
method without weighting; 4) “Rie30” is the approximation method with correct (30%, 
70%) weighting; 5) “Rie10” is the approximation method with correct (10%, 90%) 
weighting; 6) “Mid” is the mid point imputation; 7) “Diag” is the diagnosis to diagnosis 
(upper bound to upper bound) approach; 8) “Inc_rie30” is incorrect (30%, 70%) 
weighting in the approximation method; 9) “Inc_rie10” is incorrect (10%, 90%) 
weighting in the approximation method; 10) “Rie30_lp” is the approximation method 
with correct grouping based on a (30%, 70%) split on the intervals; 11) “Rie10_lp” is the 
  208 
approximation method with correct grouping based on a (10%, 90%) split on the 
intervals; 12) “Inc_rie30_lp” is the approximation method with incorrect grouping based 
on a (30%, 70%) split on the intervals; 13) “Inc_rie10_lp” is the approximation method 
with incorrect grouping based on a (10%, 90%) split on the intervals. 
 
Chapter 5: Summary and future work 
 
The serial interval is an important quantity for describing the transmission of infectious 
diseases [96]. In this thesis, we focused on estimating the serial interval for TB. We first 
conducted a systematic review on key transmission parameters for TB and found that 
there are very limited results for the serial interval due to the slow progression nature of 
TB. Secondly, we evaluated different existing methods in estimating the serial interval in 
ideal scenarios. Thirdly, we proposed to address the right censoring issue by using cure 
models [83] in a Bayesian framework and demonstrated that it can be used to estimate the 
serial interval for infectious diseases with low overall disease rate such as TB. Lastly, we 
extended the approach by Reich [92] by relaxing the uniformity assumption to address 
the doubly censoring issue in estimating the serial interval for TB. We showed that our 
approach is preferred when there is information against the uniformity assumption. 
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Both right censoring and doubly interval censoring can happen for infectious diseases 
like TB. Therefore, it is reasonable to propose an approach that addresses both issues 
simultaneously in future research. 
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